Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-109606	Intrinsic Pathway for Apoptosis	 29	0.966104978969992	1	3	26	2448	8857	0.478369138564133
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 49	0.00473320625964268	0.616381472305583	19	30	2432	8853	1.79307071665876
R-HSA-109703	PKB-mediated events	 30	0.480784505077124	1	7	23	2444	8860	1.07898816809466
R-HSA-109704	PI3K Cascade	 48	0.0197008241521195	0.778481051344359	17	31	2434	8852	1.63774989800082
R-HSA-110056	MAPK3 (ERK1) activation	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-110312	Translesion synthesis by REV1	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 23	0.213772398328635	1	7	16	2444	8867	1.40737587142781
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-110320	Translesion Synthesis by POLH	 12	0.498562181246513	1	3	9	2448	8874	1.15605875152999
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-110329	Cleavage of the damaged pyrimidine 	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-110357	Displacement of DNA glycosylase by APEX1	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  6	1	1	0	6	2451	8877	0
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 18	0.925873470520048	1	2	16	2449	8867	0.513803889568883
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 13	1	1	0	13	2451	8870	0
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-111465	Apoptotic cleavage of cellular proteins	 28	0.0258458218639237	0.844258626663093	11	17	2440	8866	1.81666375240427
R-HSA-111885	Opioid Signalling	 69	0.906629759551871	1	11	58	2440	8825	0.737196885033615
R-HSA-111931	PKA-mediated phosphorylation of CREB	 17	0.518293442627594	1	4	13	2447	8870	1.08805529555764
R-HSA-111933	Calmodulin induced events	 23	0.377922631305196	1	6	17	2445	8866	1.20632217550955
R-HSA-111957	Cam-PDE 1 activation	  5	0.0711201473144551	1	3	2	2448	8881	2.77454100367197
R-HSA-111996	Ca-dependent events	 25	0.463275720419534	1	6	19	2445	8864	1.10981640146879
R-HSA-111997	CaM pathway	 23	0.377922631305196	1	6	17	2445	8866	1.20632217550955
R-HSA-112040	G-protein mediated events	 38	0.74419669129211	1	7	31	2444	8852	0.851832764285254
R-HSA-112043	PLC beta mediated events	 37	0.717215809044273	1	7	30	2444	8853	0.874855271428099
R-HSA-112308	Presynaptic depolarization and calcium channel opening	  9	1	1	0	9	2451	8874	0
R-HSA-112310	Neurotransmitter release cycle	 39	0.87672077492227	1	6	33	2445	8850	0.7114207701723
R-HSA-112311	Neurotransmitter clearance	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-112382	Formation of RNA Pol II elongation complex 	 35	0.0106068322651534	0.616381472305583	14	21	2437	8862	1.84969400244798
R-HSA-112409	RAF-independent MAPK1/3 activation	 20	0.441643561521251	1	5	15	2446	8868	1.15605875152999
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-113418	Formation of the Early Elongation Complex	 19	0.0359441120702719	0.997257917864564	8	11	2443	8872	1.9470463183663
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	  9	0.108547342785399	1	4	5	2447	8878	2.05521555827553
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  6	1	1	0	6	2451	8877	0
R-HSA-113510	E2F mediated regulation of DNA replication	 15	0.413201927014538	1	4	11	2447	8872	1.23312933496532
R-HSA-114452	Activation of BH3-only proteins	 22	0.884407372956687	1	3	19	2448	8864	0.630577500834539
R-HSA-114508	Effects of PIP2 hydrolysis	 21	0.959405837382175	1	2	19	2449	8864	0.440403333916186
R-HSA-114604	GPVI-mediated activation cascade	 27	0.866084112677026	1	4	23	2447	8860	0.685071852758511
R-HSA-114608	Platelet degranulation 	 85	0.905081660420329	1	14	71	2437	8812	0.761638706890345
R-HSA-1169091	Activation of NF-kappaB in B cells	 51	0.889101799763795	1	8	43	2443	8840	0.725370197038424
R-HSA-1169092	Activation of RAS in B cells	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-1169408	ISG15 antiviral mechanism	 50	0.78343333421909	1	9	41	2442	8842	0.832362301101591
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 50	0.78343333421909	1	9	41	2442	8842	0.832362301101591
R-HSA-1170546	Prolactin receptor signaling	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-1181150	Signaling by NODAL	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-1187000	Fertilization	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-1221632	Meiotic synapsis	 30	0.656226925982265	1	6	24	2445	8859	0.92484700122399
R-HSA-1222556	ROS, RNS production in phagocytes	 17	0.984167108294492	1	1	16	2450	8867	0.272013823889409
R-HSA-1226099	Signaling by FGFR in disease	 39	0.0290611519921627	0.861266868131367	14	25	2437	8858	1.6599817970687
R-HSA-1227986	Signaling by ERBB2	 37	0.841879623667507	1	6	31	2445	8852	0.74987594693837
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 57	0.997224550014447	1	5	52	2446	8831	0.405634649659645
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 51	0.997833686936158	1	4	47	2447	8836	0.362685098519212
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-1236394	Signaling by ERBB4	 28	0.584086182409952	1	6	22	2445	8861	0.990907501311418
R-HSA-1236974	ER-Phagosome pathway	 63	0.83072835760282	1	11	52	2440	8831	0.807406112179674
R-HSA-1236975	Antigen processing-Cross presentation	 73	0.824997589883092	1	13	60	2438	8823	0.823493905199443
R-HSA-1236977	Endosomal/Vacuolar pathway	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 38	0.993872301121177	1	3	35	2448	8848	0.36507118469368
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-1237112	Methionine salvage pathway	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  7	1	1	0	7	2451	8876	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 17	0.745327121691444	1	3	14	2448	8869	0.816041471668227
R-HSA-1250342	PI3K events in ERBB4 signaling	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-1250347	SHC1 events in ERBB4 signaling	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-1251985	Nuclear signaling by ERBB4	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-1268020	Mitochondrial protein import	 43	0.970486576498964	1	5	38	2446	8845	0.537701744897669
R-HSA-1295596	Spry regulation of FGF signaling	 10	0.371645107075241	1	3	7	2448	8876	1.38727050183599
R-HSA-1296041	Activation of G protein gated Potassium channels	 18	1	1	0	18	2451	8865	0
R-HSA-1296052	Ca2+ activated K+ channels	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-1296059	G protein gated Potassium channels	 18	1	1	0	18	2451	8865	0
R-HSA-1296065	Inwardly rectifying K+ channels	 22	0.995328717030688	1	1	21	2450	8862	0.21019250027818
R-HSA-1296071	Potassium Channels	 66	0.928986191528171	1	10	56	2441	8827	0.700641667593932
R-HSA-1296072	Voltage gated Potassium channels	 30	0.808728421334544	1	5	25	2446	8858	0.770705834353325
R-HSA-1296346	Tandem pore domain potassium channels	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	  9	0.108547342785399	1	4	5	2447	8878	2.05521555827553
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-1368082	RORA activates gene expression	 24	0.249255319346024	1	7	17	2444	8866	1.34873521011832
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 39	0.328091210375067	1	10	29	2441	8854	1.1857012836205
R-HSA-1369062	ABC transporters in lipid homeostasis	 11	0.0676894659624027	1	5	6	2446	8877	2.1019250027818
R-HSA-139853	Elevation of cytosolic Ca2+ levels	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-140342	Apoptosis induced DNA fragmentation	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-140534	Ligand-dependent caspase activation	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 12	1	1	0	12	2451	8871	0
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-141424	Amplification of signal from the kinetochores	 52	0.90131006713717	1	8	44	2443	8839	0.7114207701723
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	 52	0.90131006713717	1	8	44	2443	8839	0.7114207701723
R-HSA-1433559	Regulation of KIT signaling	 10	0.371645107075241	1	3	7	2448	8876	1.38727050183599
R-HSA-1442490	Collagen degradation	 32	0.134793774340672	1	10	22	2441	8861	1.44507343941248
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 52	0.714743005966864	1	10	42	2441	8841	0.889275962715375
R-HSA-1461973	Defensins	  6	1	1	0	6	2451	8877	0
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-1474165	Reproduction	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-1474228	Degradation of the extracellular matrix	 75	0.67823048107931	1	15	60	2436	8823	0.92484700122399
R-HSA-1474290	Collagen formation	 55	0.780451433676718	1	10	45	2441	8838	0.840770001112718
R-HSA-1475029	Reversible hydration of carbon dioxide	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-1480926	O2/CO2 exchange in erythrocytes	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-1482788	Acyl chain remodelling of PC	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-1482801	Acyl chain remodelling of PS	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-1482839	Acyl chain remodelling of PE	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-1482922	Acyl chain remodelling of PI	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-1482925	Acyl chain remodelling of PG	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-1483115	Hydrolysis of LPC	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-1483148	Synthesis of PG	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-1483166	Synthesis of PA	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-1483191	Synthesis of PC	 19	0.0957534149087145	1	7	12	2444	8871	1.70366552857051
R-HSA-1483206	Glycerophospholipid biosynthesis	 84	0.1859769250629	1	22	62	2429	8821	1.21110916826951
R-HSA-1483213	Synthesis of PE	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-1483248	Synthesis of PIPs at the ER membrane	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-1483249	Inositol phosphate metabolism	 41	0.904872883154246	1	6	35	2445	8848	0.676717317968773
R-HSA-1483255	PI Metabolism	 62	0.988720840730849	1	7	55	2444	8828	0.522091049078059
R-HSA-1489509	DAG and IP3 signaling	 29	0.621138441801237	1	6	23	2445	8860	0.956738277128266
R-HSA-1500620	Meiosis	 41	0.541082164632918	1	9	32	2442	8851	1.01507597695316
R-HSA-1500931	Cell-Cell communication	 76	0.978971605095957	1	10	66	2441	8817	0.608451974489467
R-HSA-1502540	Signaling by Activin	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-1538133	G0 and Early G1	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-156580	Phase II - Conjugation of compounds	 42	0.572959839523176	1	9	33	2442	8850	0.990907501311418
R-HSA-156581	Methylation	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-156584	Cytosolic sulfonation of small molecules	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-156590	Glutathione conjugation	 20	0.441643561521251	1	5	15	2446	8868	1.15605875152999
R-HSA-1566948	Elastic fibre formation	 25	0.982226283864484	1	2	23	2449	8860	0.369938800489596
R-HSA-1566977	Fibronectin matrix formation	  5	1	1	0	5	2451	8878	0
R-HSA-156711	Polo-like kinase mediated events	  6	1	1	0	6	2451	8877	0
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 32	0.38701662629774	1	8	24	2443	8859	1.15605875152999
R-HSA-156842	Eukaryotic Translation Elongation	 20	0.441643561521251	1	5	15	2446	8868	1.15605875152999
R-HSA-156902	Peptide chain elongation	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-157118	Signaling by NOTCH	 85	0.375211975419254	1	20	65	2431	8818	1.08805529555764
R-HSA-157579	Telomere Maintenance	 34	0.955110787416232	1	4	30	2447	8853	0.544027647778818
R-HSA-157858	Gap junction trafficking and regulation	 29	0.966104978969992	1	3	26	2448	8857	0.478369138564133
R-HSA-15869	Metabolism of nucleotides	 64	0.40977108227258	1	15	49	2436	8834	1.08380507955936
R-HSA-1592230	Mitochondrial biogenesis	 71	0.869298822058409	1	12	59	2439	8824	0.78156084610478
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 27	0.545252305922331	1	6	21	2445	8862	1.02760777913777
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 28	0.584086182409952	1	6	22	2445	8861	0.990907501311418
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 32	0.555612104948579	1	7	25	2444	8858	1.01155140758874
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 33	0.591187602985767	1	7	26	2444	8857	0.980898334631505
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 53	0.00545357341632142	0.616381472305583	20	33	2431	8850	1.74499434193206
R-HSA-1592389	Activation of Matrix Metalloproteinases	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-159418	Recycling of bile acids and salts	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-159740	Gamma-carboxylation of protein precursors	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-1614517	Sulfide oxidation to sulfate	  5	1	1	0	5	2451	8878	0
R-HSA-1614558	Degradation of cysteine and homocysteine	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-1614635	Sulfur amino acid metabolism	 17	0.518293442627594	1	4	13	2447	8870	1.08805529555764
R-HSA-162587	HIV Life Cycle	 98	0.279657247307958	1	24	74	2427	8809	1.13246571578448
R-HSA-162588	Budding and maturation of HIV virion	 16	0.252730051086096	1	5	11	2446	8872	1.44507343941248
R-HSA-162592	Integration of provirus	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-162594	Early Phase of HIV Life Cycle	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-162599	Late Phase of HIV Life Cycle	 88	0.255893737821553	1	22	66	2429	8817	1.15605875152999
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-162791	Attachment of GPI anchor to uPAR	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-162909	Host Interactions of HIV factors	100	0.990431030314693	1	13	87	2438	8796	0.601150550795594
R-HSA-1630316	Glycosaminoglycan metabolism	 82	0.958642056372072	1	12	70	2439	8813	0.676717317968773
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 51	0.999559859694128	1	3	48	2448	8835	0.272013823889409
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	 73	0.824997589883092	1	13	60	2438	8823	0.823493905199443
R-HSA-163210	Formation of ATP by chemiosmotic coupling	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-1632852	Macroautophagy	 52	0.453178391249916	1	12	40	2439	8843	1.06713115525845
R-HSA-163359	Glucagon signaling in metabolic regulation	 26	0.845148347080803	1	4	22	2447	8861	0.7114207701723
R-HSA-163560	Triglyceride catabolism	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-163615	PKA activation	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-163685	Integration of energy metabolism	 88	0.960308841956718	1	13	75	2438	8808	0.683125625904084
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-1638074	Keratan sulfate/keratin metabolism	 24	0.917595809845244	1	3	21	2448	8862	0.578029375764994
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 39	0.945305875868289	1	5	34	2446	8849	0.59285064181025
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 20	0.656579033519929	1	4	16	2447	8867	0.92484700122399
R-HSA-1643713	Signaling by EGFR in Cancer	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-164378	PKA activation in glucagon signalling	 15	0.413201927014538	1	4	11	2447	8872	1.23312933496532
R-HSA-164843	2-LTR circle formation	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 14	0.611064798870095	1	3	11	2448	8872	0.990907501311418
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-164944	Nef and signal transduction	  5	1	1	0	5	2451	8878	0
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 19	0.812284330105899	1	3	16	2448	8867	0.730142369387361
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 28	0.755350632400901	1	5	23	2446	8860	0.825756251092848
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 42	0.916740280947205	1	6	36	2445	8847	0.660605000874279
R-HSA-165159	mTOR signalling	 30	0.480784505077124	1	7	23	2444	8860	1.07898816809466
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 43	0.0641775185454765	1	14	29	2437	8854	1.50556488571347
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	 89	0.666980856588817	1	18	71	2433	8812	0.935238540563586
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 40	0.983821531221465	1	4	36	2447	8847	0.462423500611995
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-166054	Activated TLR4 signalling	 81	0.59921913464274	1	17	64	2434	8819	0.970518458074558
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 68	0.827589958427267	1	12	56	2439	8827	0.816041471668227
R-HSA-1660661	Sphingolipid de novo biosynthesis	 31	0.518731843993708	1	7	24	2444	8859	1.04418209815612
R-HSA-1660662	Glycosphingolipid metabolism	 29	0.783311505442497	1	5	24	2446	8859	0.797281897606888
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade 	 74	0.433764055252215	1	17	57	2434	8826	1.06232425816269
R-HSA-166208	mTORC1-mediated signalling	 17	0.745327121691444	1	3	14	2448	8869	0.816041471668227
R-HSA-1663150	The activation of arylsulfatases	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-166658	Complement cascade	 29	0.966104978969992	1	3	26	2448	8857	0.478369138564133
R-HSA-166663	Initial triggering of complement	 17	1	1	0	17	2451	8866	0
R-HSA-166786	Creation of C4 and C2 activators	 13	1	1	0	13	2451	8870	0
R-HSA-167021	PLC-gamma1 signalling	 31	0.689225745659518	1	6	25	2445	8858	0.895013226990958
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 25	0.0717358386304538	1	9	16	2442	8867	1.66472460220318
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 19	0.0359441120702719	0.997257917864564	8	11	2443	8872	1.9470463183663
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 15	0.208470055549927	1	5	10	2446	8873	1.54141166870665
R-HSA-167161	HIV Transcription Initiation	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-167169	HIV Transcription Elongation	 24	0.127599590143546	1	8	16	2443	8867	1.54141166870665
R-HSA-167172	Transcription of the HIV genome	 43	0.203577537323369	1	12	31	2439	8852	1.29048418775441
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 24	0.127599590143546	1	8	16	2443	8867	1.54141166870665
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 24	0.127599590143546	1	8	16	2443	8867	1.54141166870665
R-HSA-167287	HIV elongation arrest and recovery	 17	0.518293442627594	1	4	13	2447	8870	1.08805529555764
R-HSA-167290	Pausing and recovery of HIV elongation	 17	0.518293442627594	1	4	13	2447	8870	1.08805529555764
R-HSA-167590	Nef Mediated CD4 Down-regulation	  8	1	1	0	8	2451	8875	0
R-HSA-1679131	Trafficking and processing of endosomal TLR	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 71	0.869298822058409	1	12	59	2439	8824	0.78156084610478
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 62	0.814379761740266	1	11	51	2440	8832	0.820428791408378
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 74	0.433764055252215	1	17	57	2434	8826	1.06232425816269
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 62	0.814379761740266	1	11	51	2440	8832	0.820428791408378
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 68	0.827589958427267	1	12	56	2439	8827	0.816041471668227
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 67	0.811644851935794	1	12	55	2439	8828	0.828221195125961
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 68	0.827589958427267	1	12	56	2439	8827	0.816041471668227
R-HSA-168253	Host Interactions with Influenza Factors	 31	0.518731843993708	1	7	24	2444	8859	1.04418209815612
R-HSA-168254	Influenza Infection	 67	0.605682146701566	1	14	53	2437	8830	0.966258060980288
R-HSA-168255	Influenza Life Cycle	 60	0.669888545567416	1	12	48	2439	8835	0.92484700122399
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 24	0.617159924906092	1	5	19	2446	8864	0.963382292941657
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 52	0.587403992048834	1	11	41	2440	8842	0.978203558986913
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 26	0.69152410435063	1	5	21	2446	8862	0.889275962715375
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 29	0.442052521410029	1	7	22	2444	8861	1.11619465664964
R-HSA-168325	Viral Messenger RNA Synthesis	 31	0.689225745659518	1	6	25	2445	8858	0.895013226990958
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 25	0.655630976027731	1	5	20	2446	8863	0.92484700122399
R-HSA-168638	NOD1/2 Signaling Pathway	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 30	0.808728421334544	1	5	25	2446	8858	0.770705834353325
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	1	1	0	10	2451	8873	0
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	 52	0.714743005966864	1	10	42	2441	8841	0.889275962715375
R-HSA-169911	Regulation of Apoptosis	 39	0.994966861709874	1	3	36	2448	8847	0.35571038508615
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 24	0.617159924906092	1	5	19	2446	8864	0.963382292941657
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 56	0.799748874581827	1	10	46	2441	8837	0.825756251092848
R-HSA-171007	p38MAPK events	 10	1	1	0	10	2451	8873	0
R-HSA-171306	Packaging Of Telomere Ends	 16	0.890420799755764	1	2	14	2449	8869	0.578029375764994
R-HSA-173623	Classical antibody-mediated complement activation	  9	1	1	0	9	2451	8874	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 45	0.998487959132461	1	3	42	2448	8841	0.30828233374133
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 39	0.994966861709874	1	3	36	2448	8847	0.35571038508615
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 56	0.996685641673254	1	5	51	2446	8832	0.412878125546424
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 47	0.995420531075367	1	4	43	2447	8840	0.393551915414464
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 48	0.986893314498357	1	5	43	2446	8840	0.481691146470828
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 50	0.997383584849878	1	4	46	2447	8837	0.369938800489596
R-HSA-174403	Glutathione synthesis and recycling	  9	0.108547342785399	1	4	5	2447	8878	2.05521555827553
R-HSA-174411	Polymerase switching on the C-strand of the telomere	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-174414	Processive synthesis on the C-strand of the telomere	  7	1	1	0	7	2451	8876	0
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 16	0.890420799755764	1	2	14	2449	8869	0.578029375764994
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  7	1	1	0	7	2451	8876	0
R-HSA-174490	Membrane binding and targetting of GAG proteins	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	 39	0.87672077492227	1	6	33	2445	8850	0.7114207701723
R-HSA-175474	Assembly Of The HIV Virion	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-176033	Interactions of Vpr with host cellular proteins	 30	0.656226925982265	1	6	24	2445	8859	0.92484700122399
R-HSA-176187	Activation of ATR in response to replication stress	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 54	0.998777799552048	1	4	50	2447	8833	0.342535926379256
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 52	0.998208203546236	1	4	48	2447	8835	0.35571038508615
R-HSA-176412	Phosphorylation of the APC/C	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 52	0.998208203546236	1	4	48	2447	8835	0.35571038508615
R-HSA-176974	Unwinding of DNA	  6	1	1	0	6	2451	8877	0
R-HSA-177243	Interactions of Rev with host cellular proteins	 29	0.783311505442497	1	5	24	2446	8859	0.797281897606888
R-HSA-177504	Retrograde neurotrophin signalling	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 34	0.955110787416232	1	4	30	2447	8853	0.544027647778818
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 50	0.997383584849878	1	4	46	2447	8837	0.369938800489596
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 37	0.00718357900594555	0.616381472305583	15	22	2436	8861	1.87468986734593
R-HSA-180024	DARPP-32 events	 23	0.213772398328635	1	7	16	2444	8867	1.40737587142781
R-HSA-180534	Vpu mediated degradation of CD4	 39	0.994966861709874	1	3	36	2448	8847	0.35571038508615
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 40	0.983821531221465	1	4	36	2447	8847	0.462423500611995
R-HSA-180746	Nuclear import of Rev protein	 26	0.69152410435063	1	5	21	2446	8862	0.889275962715375
R-HSA-180786	Extension of Telomeres	 18	0.925873470520048	1	2	16	2449	8867	0.513803889568883
R-HSA-180910	Vpr-mediated nuclear import of PICs	 27	0.545252305922331	1	6	21	2445	8862	1.02760777913777
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 16	0.890420799755764	1	2	14	2449	8869	0.578029375764994
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 68	0.827589958427267	1	12	56	2439	8827	0.816041471668227
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	1	1	0	6	2451	8877	0
R-HSA-182971	EGFR downregulation	 18	0.175701284424564	1	6	12	2445	8871	1.54141166870665
R-HSA-1834941	STING mediated induction of host immune responses	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 49	0.762029023163215	1	9	40	2442	8843	0.849349286838358
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-1839124	FGFR1 mutant receptor activation	 20	0.0488627100496935	1	8	12	2443	8871	1.84969400244798
R-HSA-1839126	FGFR2 mutant receptor activation	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-186712	Regulation of beta-cell development	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-187015	Activation of TRKA receptors	  5	1	1	0	5	2451	8878	0
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 45	0.998487959132461	1	3	42	2448	8841	0.30828233374133
R-HSA-189200	Cellular hexose transport	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-189445	Metabolism of porphyrins	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-189451	Heme biosynthesis	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-190236	Signaling by FGFR	 49	0.0111406545750322	0.616381472305583	18	31	2433	8852	1.69869857367672
R-HSA-190241	FGFR2 ligand binding and activation	  5	0.0711201473144551	1	3	2	2448	8881	2.77454100367197
R-HSA-190242	FGFR1 ligand binding and activation	  5	0.00902812579105142	0.616381472305583	4	1	2447	8882	3.69938800489596
R-HSA-190373	FGFR1c ligand binding and activation	  5	0.00902812579105142	0.616381472305583	4	1	2447	8882	3.69938800489596
R-HSA-190828	Gap junction trafficking	 28	0.9593426917684	1	3	25	2448	8858	0.495453750655709
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 10	1	1	0	10	2451	8873	0
R-HSA-190861	Gap junction assembly	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-190872	Transport of connexons to the plasma membrane	 11	1	1	0	11	2451	8872	0
R-HSA-190873	Gap junction degradation	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  5	1	1	0	5	2451	8878	0
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 22	0.0827731490262246	1	8	14	2443	8869	1.68154000222544
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-1912422	Pre-NOTCH Expression and Processing	 32	0.134793774340672	1	10	22	2441	8861	1.44507343941248
R-HSA-191273	Cholesterol biosynthesis	 20	0.441643561521251	1	5	15	2446	8868	1.15605875152999
R-HSA-191859	snRNP Assembly	 36	0.530617897626014	1	8	28	2443	8855	1.02760777913777
R-HSA-192105	Synthesis of bile acids and bile salts	 18	0.175701284424564	1	6	12	2445	8871	1.54141166870665
R-HSA-192823	Viral mRNA Translation	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-193048	Androgen biosynthesis	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 11	0.198790784258893	1	4	7	2447	8876	1.68154000222544
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-193639	p75NTR signals via NF-kB	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-193648	NRAGE signals death through JNK	 39	0.629418751604253	1	8	31	2443	8852	0.9485610268964
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-193692	Regulated proteolysis of p75NTR	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-193704	p75 NTR receptor-mediated signalling	 68	0.629699503089593	1	14	54	2437	8829	0.952048383612931
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-194068	Bile acid and bile salt metabolism	 20	0.121002255986649	1	7	13	2444	8870	1.61848225214198
R-HSA-194313	VEGF ligand-receptor interactions	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-194441	Metabolism of non-coding RNA	 36	0.530617897626014	1	8	28	2443	8855	1.02760777913777
R-HSA-194840	Rho GTPase cycle	 97	0.345733284252203	1	23	74	2428	8809	1.09646809423463
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 69	0.975894921464941	1	9	60	2442	8823	0.603161087754776
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-196025	Formation of annular gap junctions	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-196071	Metabolism of steroid hormones	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-196108	Pregnenolone biosynthesis	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-196299	Beta-catenin phosphorylation cascade	 16	0.111098065370354	1	6	10	2445	8873	1.73408812729498
R-HSA-1963640	GRB2 events in ERBB2 signaling	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-1963642	PI3K events in ERBB2 signaling	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-196757	Metabolism of folate and pterines	 12	0.498562181246513	1	3	9	2448	8874	1.15605875152999
R-HSA-196780	Biotin transport and metabolism	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-196783	Coenzyme A biosynthesis	  6	1	1	0	6	2451	8877	0
R-HSA-196807	Nicotinate metabolism	 19	0.0957534149087145	1	7	12	2444	8871	1.70366552857051
R-HSA-196836	Vitamin C (ascorbate) metabolism	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	 76	0.129084321322881	1	21	55	2430	8828	1.27774914642788
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 18	0.925873470520048	1	2	16	2449	8867	0.513803889568883
R-HSA-197264	Nicotinamide salvaging	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-1980143	Signaling by NOTCH1	 59	0.645458082067169	1	12	47	2439	8836	0.940522374126092
R-HSA-1980145	Signaling by NOTCH2	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-1980148	Signaling by NOTCH3	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-1980150	Signaling by NOTCH4	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-198323	AKT phosphorylates targets in the cytosol	 13	1	1	0	13	2451	8870	0
R-HSA-198693	AKT phosphorylates targets in the nucleus	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 22	0.533138525816575	1	5	17	2446	8866	1.0509625013909
R-HSA-198753	ERK/MAPK targets	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 52	0.999953065355742	1	2	50	2449	8833	0.177855192543075
R-HSA-1989781	PPARA activates gene expression	 86	0.219654021918432	1	22	64	2429	8819	1.18294383877487
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-199418	Negative regulation of the PI3K/AKT network	 61	0.45016239505009	1	14	47	2437	8836	1.06129983747015
R-HSA-199920	CREB phosphorylation	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-199992	trans-Golgi Network Vesicle Budding	 53	0.0916969024137072	1	16	37	2435	8846	1.39599547354565
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-201451	Signaling by BMP	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-201688	WNT mediated activation of DVL	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 37	0.841879623667507	1	6	31	2445	8852	0.74987594693837
R-HSA-202040	G-protein activation	 20	0.992387669376172	1	1	19	2450	8864	0.231211750305998
R-HSA-202131	Metabolism of nitric oxide	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 35	0.495544149287108	1	8	27	2443	8856	1.05696800139885
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	  7	1	1	0	7	2451	8876	0
R-HSA-2022854	Keratan sulfate biosynthesis	 20	0.839761735385776	1	3	17	2448	8866	0.693635250917993
R-HSA-2022857	Keratan sulfate degradation	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-2022870	Chondroitin sulfate biosynthesis	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-2022928	HS-GAG biosynthesis	 20	0.839761735385776	1	3	17	2448	8866	0.693635250917993
R-HSA-202403	TCR signaling	 75	0.911947247525829	1	12	63	2439	8820	0.739877600979192
R-HSA-2024096	HS-GAG degradation	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-2024101	CS/DS degradation	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-202424	Downstream TCR signaling	 64	0.911233326385022	1	10	54	2441	8829	0.722536719706242
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	  5	1	1	0	5	2451	8878	0
R-HSA-202433	Generation of second messenger molecules	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-202670	ERKs are inactivated	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-202733	Cell surface interactions at the vascular wall	 87	0.976958907100698	1	12	75	2439	8808	0.63782551808551
R-HSA-2028269	Signaling by Hippo	 16	1	1	0	16	2451	8867	0
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 68	0.89640522259189	1	11	57	2440	8826	0.748038015695874
R-HSA-2029481	FCGR activation	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 48	0.73917351041847	1	9	39	2442	8844	0.867044063647491
R-HSA-2029485	Role of phospholipids in phagocytosis	 19	0.990282770644334	1	1	18	2450	8865	0.243380789795787
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-203615	eNOS activation	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-203641	NOSTRIN mediated eNOS trafficking	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-203765	eNOS activation and regulation	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-203927	MicroRNA (miRNA) biogenesis	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 53	0.482207859956649	1	12	41	2439	8842	1.04699660515923
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 12	0.0960216152047865	1	5	7	2446	8876	1.92676458588331
R-HSA-2046105	Linoleic acid (LA) metabolism	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 12	0.0960216152047865	1	5	7	2446	8876	1.92676458588331
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 48	0.73917351041847	1	9	39	2442	8844	0.867044063647491
R-HSA-205025	NADE modulates death signalling	  6	1	1	0	6	2451	8877	0
R-HSA-205043	NRIF signals cell death from the nucleus	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-209543	p75NTR recruits signalling complexes	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-209560	NF-kB is activated and signals survival	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-209952	Peptide hormone biosynthesis	  6	1	1	0	6	2451	8877	0
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 21	0.959405837382175	1	2	19	2449	8864	0.440403333916186
R-HSA-210745	Regulation of gene expression in beta cells	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-210990	PECAM1 interactions	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-210991	Basigin interactions	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-210993	Tie2 Signaling	 12	0.498562181246513	1	3	9	2448	8874	1.15605875152999
R-HSA-211000	Gene Silencing by RNA	 66	0.347546397033489	1	16	50	2435	8833	1.12102666815029
R-HSA-211227	Activation of DNA fragmentation factor	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 37	0.99254845264291	1	3	34	2448	8849	0.374937973469185
R-HSA-211859	Biological oxidations	 88	0.960308841956718	1	13	75	2438	8808	0.683125625904084
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 24	0.917595809845244	1	3	21	2448	8862	0.578029375764994
R-HSA-211945	Phase I - Functionalization of compounds	 46	0.994493923840317	1	4	42	2447	8841	0.402107391836518
R-HSA-211976	Endogenous sterols	 12	0.498562181246513	1	3	9	2448	8874	1.15605875152999
R-HSA-211981	Xenobiotics	  6	1	1	0	6	2451	8877	0
R-HSA-212165	Epigenetic regulation of gene expression	 74	0.23557767127132	1	19	55	2432	8828	1.18730358265242
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 38	0.936512914208543	1	5	33	2446	8850	0.608451974489467
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 22	0.180317112566229	1	7	15	2444	8868	1.47134750194726
R-HSA-212300	PRC2 methylates histones and DNA	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 18	0.780911847318683	1	3	15	2448	8868	0.770705834353325
R-HSA-212718	EGFR interacts with phospholipase C-gamma	 30	0.656226925982265	1	6	24	2445	8859	0.92484700122399
R-HSA-2129379	Molecules associated with elastic fibres	 21	0.959405837382175	1	2	19	2449	8864	0.440403333916186
R-HSA-2132295	MHC class II antigen presentation	 79	0.969915080986712	1	11	68	2440	8815	0.643880823636955
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-2142753	Arachidonic acid metabolism	 25	0.982226283864484	1	2	23	2449	8860	0.369938800489596
R-HSA-2142789	Ubiquinol biosynthesis	  6	1	1	0	6	2451	8877	0
R-HSA-2142845	Hyaluronan metabolism	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 47	0.82716208895483	1	8	39	2443	8844	0.787103830828928
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-216083	Integrin cell surface interactions	 53	0.737949435266661	1	10	43	2441	8840	0.872497170966028
R-HSA-2160916	Hyaluronan uptake and degradation	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-2161522	Abacavir transport and metabolism	  6	1	1	0	6	2451	8877	0
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-2168880	Scavenging of heme from plasma	  9	1	1	0	9	2451	8874	0
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 29	0.992372900186369	1	2	27	2449	8856	0.318912759042755
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 20	0.839761735385776	1	3	17	2448	8866	0.693635250917993
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 24	0.794972588651797	1	4	20	2447	8863	0.770705834353325
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 10	1	1	0	10	2451	8873	0
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 32	0.38701662629774	1	8	24	2443	8859	1.15605875152999
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 17	0.298989658837395	1	5	12	2446	8871	1.36006911944704
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-2179392	EGFR Transactivation by Gastrin	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-2187338	Visual phototransduction	 49	0.86090239617408	1	8	41	2443	8842	0.754977143856319
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	  7	1	1	0	7	2451	8876	0
R-HSA-2214320	Anchoring fibril formation	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 54	0.173599802149024	1	15	39	2436	8844	1.28450972392221
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 32	0.067051202332914	1	11	21	2440	8862	1.58958078335373
R-HSA-2243919	Crosslinking of collagen fibrils	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-2262749	Cellular response to hypoxia	 57	0.997224550014447	1	5	52	2446	8831	0.405634649659645
R-HSA-2299718	Condensation of Prophase Chromosomes	 18	0.346408264380791	1	5	13	2446	8870	1.28450972392221
R-HSA-2408517	SeMet incorporation into proteins	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-2408522	Selenoamino acid metabolism	 38	0.441045226203719	1	9	29	2442	8854	1.09521355408104
R-HSA-2408557	Selenocysteine synthesis	 22	0.335100831398267	1	6	16	2445	8867	1.26115500166908
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 34	0.0981420668043028	1	11	23	2440	8860	1.49607603139175
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-2453864	Retinoid cycle disease events	  5	1	1	0	5	2451	8878	0
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-2465910	MASTL Facilitates Mitotic Progression	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-2474795	Diseases associated with visual transduction	  5	1	1	0	5	2451	8878	0
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 71	0.960576762575528	1	10	61	2441	8822	0.651300705087317
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  5	0.0711201473144551	1	3	2	2448	8881	2.77454100367197
R-HSA-2514856	The phototransduction cascade	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 16	0.466692552324018	1	4	12	2447	8871	1.15605875152999
R-HSA-2559580	Oxidative Stress Induced Senescence	 53	0.242465737173831	1	14	39	2437	8844	1.22149603935244
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 46	0.994493923840317	1	4	42	2447	8841	0.402107391836518
R-HSA-2559583	Cellular Senescence	100	0.843154079379203	1	18	82	2433	8801	0.832362301101591
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-2559585	Oncogene Induced Senescence	 21	0.0644459741711287	1	8	13	2443	8870	1.76161333566474
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 31	0.927214437210831	1	4	27	2447	8856	0.596675484660639
R-HSA-2562578	TRIF-mediated programmed cell death	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 62	0.0339261593948169	0.983104707796473	20	42	2431	8841	1.4916887116516
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	1	1	0	5	2451	8878	0
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	1	1	0	5	2451	8878	0
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 11	0.198790784258893	1	4	7	2447	8876	1.68154000222544
R-HSA-264876	Insulin processing	 25	0.286342449053089	1	7	18	2444	8865	1.29478580171359
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-2672351	Stimuli-sensing channels	 61	0.0286292918987601	0.861266868131367	20	41	2431	8842	1.51614262495736
R-HSA-2682334	EPH-Ephrin signaling	 69	0.975894921464941	1	9	60	2442	8823	0.603161087754776
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 22	0.884407372956687	1	3	19	2448	8864	0.630577500834539
R-HSA-2871837	FCERI mediated NF-kB activation	 62	0.889873974178904	1	10	52	2441	8831	0.745844355825799
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 15	0.413201927014538	1	4	11	2447	8872	1.23312933496532
R-HSA-2980736	Peptide hormone metabolism	 52	0.714743005966864	1	10	42	2441	8841	0.889275962715375
R-HSA-2980766	Nuclear Envelope Breakdown	 40	0.508345554400981	1	9	31	2442	8852	1.04045287637699
R-HSA-2990846	SUMOylation	 80	0.189824029444336	1	21	59	2430	8824	1.21386168910649
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-2995410	Nuclear Envelope Reassembly	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-3000157	Laminin interactions	 23	0.765337144694179	1	4	19	2447	8864	0.804214783673035
R-HSA-3000170	Syndecan interactions	 20	0.121002255986649	1	7	13	2444	8870	1.61848225214198
R-HSA-3000171	Non-integrin membrane-ECM interactions	 45	0.78736711176867	1	8	37	2443	8846	0.822086223310214
R-HSA-3000178	ECM proteoglycans	 47	0.908432717918814	1	7	40	2444	8843	0.688715851975312
R-HSA-3000480	Scavenging by Class A Receptors	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 53	0.154623514987621	1	15	38	2436	8845	1.30874575644904
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	 77	0.143050697572403	1	21	56	2430	8827	1.26115500166908
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-3214815	HDACs deacetylate histones	 33	0.99677749857791	1	2	31	2449	8852	0.280256667037573
R-HSA-3214841	PKMTs methylate histone lysines	 33	0.273085643445521	1	9	24	2442	8859	1.26115500166908
R-HSA-3214842	HDMs demethylate histones	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-3214847	HATs acetylate histones	 72	0.717809016867765	1	14	58	2437	8825	0.899156806745546
R-HSA-3214858	RMTs methylate histone arginines	 30	0.314790289361004	1	8	22	2443	8861	1.23312933496532
R-HSA-3215018	Processing and activation of SUMO	  5	1	1	0	5	2451	8878	0
R-HSA-3232118	SUMOylation of transcription factors	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-3238698	WNT ligand biogenesis and trafficking	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-3270619	IRF3-mediated induction of type I IFN	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-3295583	TRP channels	 11	0.198790784258893	1	4	7	2447	8876	1.68154000222544
R-HSA-3296469	Defects in cobalamin (B12) metabolism	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 11	0.0676894659624027	1	5	6	2446	8877	2.1019250027818
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 27	0.545252305922331	1	6	21	2445	8862	1.02760777913777
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-3322077	Glycogen synthesis	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-3371378	Regulation by c-FLIP	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 62	0.889873974178904	1	10	52	2441	8831	0.745844355825799
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	 41	0.999444483385007	1	2	39	2449	8844	0.225572439322924
R-HSA-3371511	HSF1 activation	 21	0.959405837382175	1	2	19	2449	8864	0.440403333916186
R-HSA-3371556	Cellular response to heat stress	 78	0.888762723823457	1	13	65	2438	8818	0.770705834353325
R-HSA-3371568	Attenuation phase	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-3371571	HSF1-dependent transactivation	 26	0.998241486104852	1	1	25	2450	8858	0.177855192543075
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 38	0.97710355372979	1	4	34	2447	8849	0.486761579591574
R-HSA-350054	Notch-HLH transcription pathway	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 41	0.996615591630617	1	3	38	2448	8845	0.338358658984387
R-HSA-351202	Metabolism of polyamines	 62	0.999744507114202	1	4	58	2447	8825	0.298337742330319
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  7	1	1	0	7	2451	8876	0
R-HSA-352230	Amino acid transport across the plasma membrane	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-354192	Integrin alphaIIb beta3 signaling	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 18	0.780911847318683	1	3	15	2448	8868	0.770705834353325
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-3595172	Defective CHST3 causes SEDCJD	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3595177	Defective CHSY1 causes TPBS	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3656237	Defective EXT2 causes exostoses 2	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-373080	Class B/2 (Secretin family receptors)	 49	0.969144373327537	1	6	43	2445	8840	0.566232857892239
R-HSA-373752	Netrin-1 signaling	 38	0.597729044803855	1	8	30	2443	8853	0.973523159183148
R-HSA-373753	Nephrin family interactions	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-373755	Semaphorin interactions	 53	0.998519445982267	1	4	49	2447	8834	0.348998868386411
R-HSA-373760	L1CAM interactions	 85	0.848213773394773	1	15	70	2436	8813	0.816041471668227
R-HSA-375170	CDO in myogenesis	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-375276	Peptide ligand-binding receptors	 75	0.99998174718236	1	4	71	2447	8812	0.246625866993064
R-HSA-375280	Amine ligand-binding receptors	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-376172	DSCAM interactions	  8	1	1	0	8	2451	8875	0
R-HSA-376176	Signaling by Robo receptor	 25	0.286342449053089	1	7	18	2444	8865	1.29478580171359
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 28	0.998921210117185	1	1	27	2450	8856	0.16515125021857
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-3781865	Diseases of glycosylation	 42	0.965464248014464	1	5	37	2446	8846	0.550504167395232
R-HSA-379716	Cytosolic tRNA aminoacylation	 21	0.959405837382175	1	2	19	2449	8864	0.440403333916186
R-HSA-379724	tRNA Aminoacylation	 32	0.720059662746658	1	6	26	2445	8857	0.867044063647491
R-HSA-379726	Mitochondrial tRNA aminoacylation	 14	0.358606761290642	1	4	10	2447	8873	1.32121000174856
R-HSA-380108	Chemokine receptors bind chemokines	 19	0.990282770644334	1	1	18	2450	8865	0.243380789795787
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 52	0.0098606938414922	0.616381472305583	19	33	2432	8850	1.68962432915921
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 58	0.0164276051171422	0.719093747303053	20	38	2431	8845	1.59456379521378
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 52	0.0098606938414922	0.616381472305583	19	33	2432	8850	1.68962432915921
R-HSA-380287	Centrosome maturation	 58	0.0164276051171422	0.719093747303053	20	38	2431	8845	1.59456379521378
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 64	0.0466433638517259	1	20	44	2431	8839	1.44507343941248
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 22	0.335100831398267	1	6	16	2445	8867	1.26115500166908
R-HSA-380994	ATF4 activates genes	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	 10	0.0446919905550624	1	5	5	2446	8878	2.31211750305998
R-HSA-381038	XBP1(S) activates chaperone genes	 41	0.813992329395731	1	7	34	2444	8849	0.789503537630236
R-HSA-381042	PERK regulates gene expression	 24	0.794972588651797	1	4	20	2447	8863	0.770705834353325
R-HSA-381070	IRE1alpha activates chaperones	 42	0.83366849639649	1	7	35	2444	8848	0.770705834353325
R-HSA-381119	Unfolded Protein Response (UPR)	 73	0.737645694103355	1	14	59	2437	8824	0.886839590214785
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  8	0.0723449015945121	1	4	4	2447	8879	2.31211750305998
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 66	0.695140057754735	1	13	53	2438	8830	0.910834167872112
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 78	0.966066813285423	1	11	67	2440	8816	0.652135705991275
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 34	0.955110787416232	1	4	30	2447	8853	0.544027647778818
R-HSA-381753	Olfactory Signaling Pathway	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-382556	ABC-family proteins mediated transport	 70	0.337483363502777	1	17	53	2434	8830	1.12302850148627
R-HSA-383280	Nuclear Receptor transcription pathway	 27	0.545252305922331	1	6	21	2445	8862	1.02760777913777
R-HSA-388841	Costimulation by the CD28 family	 40	0.659687050905071	1	8	32	2443	8851	0.92484700122399
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	 17	0.745327121691444	1	3	14	2448	8869	0.816041471668227
R-HSA-389356	CD28 co-stimulation	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-389359	CD28 dependent Vav1 pathway	  8	1	1	0	8	2451	8875	0
R-HSA-389513	CTLA4 inhibitory signaling	 18	0.175701284424564	1	6	12	2445	8871	1.54141166870665
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 18	0.925873470520048	1	2	16	2449	8867	0.513803889568883
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-389948	PD-1 signaling	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 19	0.990282770644334	1	1	18	2450	8865	0.243380789795787
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 20	0.992387669376172	1	1	19	2450	8864	0.231211750305998
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 18	1	1	0	18	2451	8865	0
R-HSA-389977	Post-chaperonin tubulin folding pathway	 14	1	1	0	14	2451	8869	0
R-HSA-390247	Beta-oxidation of very long chain fatty acids	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-390450	Folding of actin by CCT/TriC	 10	1	1	0	10	2451	8873	0
R-HSA-390466	Chaperonin-mediated protein folding	 60	0.963886622968847	1	8	52	2443	8831	0.61656466748266
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 28	0.884539692723047	1	4	24	2447	8859	0.660605000874279
R-HSA-390522	Striated Muscle Contraction	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-390666	Serotonin receptors	  6	1	1	0	6	2451	8877	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 24	0.978104012797265	1	2	22	2449	8861	0.385352917176663
R-HSA-390918	Peroxisomal lipid metabolism	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-391160	Signal regulatory protein family interactions	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-391251	Protein folding	 65	0.981805609242877	1	8	57	2443	8826	0.56913661613784
R-HSA-391903	Eicosanoid ligand-binding receptors	  5	1	1	0	5	2451	8878	0
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 16	0.252730051086096	1	5	11	2446	8872	1.44507343941248
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 17	0.984167108294492	1	1	16	2450	8867	0.272013823889409
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 28	0.990561319412826	1	2	26	2449	8857	0.330302500437139
R-HSA-392517	Rap1 signalling	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-392518	Signal amplification	 25	0.821513848199238	1	4	21	2447	8862	0.739877600979192
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-3928662	EPHB-mediated forward signaling	 33	0.947146052946393	1	4	29	2447	8854	0.560513334075146
R-HSA-3928663	EPHA-mediated growth cone collapse	 24	0.794972588651797	1	4	20	2447	8863	0.770705834353325
R-HSA-3928664	Ephrin signaling	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 34	0.887410544422599	1	5	29	2446	8854	0.680034559723522
R-HSA-397795	G-protein beta:gamma signalling	 30	0.993842722074865	1	2	28	2449	8855	0.30828233374133
R-HSA-399719	Trafficking of AMPA receptors	 28	0.9593426917684	1	3	25	2448	8858	0.495453750655709
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	 28	0.9593426917684	1	3	25	2448	8858	0.495453750655709
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 13	1	1	0	13	2451	8870	0
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-399956	CRMPs in Sema3A signaling	 13	1	1	0	13	2451	8870	0
R-HSA-399997	Acetylcholine regulates insulin secretion	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 23	0.996340855870662	1	1	22	2450	8861	0.201053695918259
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	 88	0.255893737821553	1	22	66	2429	8817	1.15605875152999
R-HSA-400253	Circadian Clock	 55	0.409651931179328	1	13	42	2438	8841	1.09300100144653
R-HSA-400451	Free fatty acids regulate insulin secretion	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-400685	Sema4D in semaphorin signaling	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-4085001	Sialic acid metabolism	 24	0.978104012797265	1	2	22	2449	8861	0.385352917176663
R-HSA-4086398	Ca2+ pathway	 49	0.637593453775159	1	10	39	2441	8844	0.943721429820398
R-HSA-4086400	PCP/CE pathway	 68	0.998593939775189	1	6	62	2445	8821	0.408020735834113
R-HSA-416476	G alpha (q) signalling events	 89	0.999567695318838	1	8	81	2443	8802	0.415661573583816
R-HSA-416482	G alpha (12/13) signalling events	 56	0.939380242182445	1	8	48	2443	8835	0.660605000874279
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 19	0.939236898804065	1	2	17	2449	8866	0.486761579591574
R-HSA-416700	Other semaphorin interactions	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-417957	P2Y receptors	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-418038	Nucleotide-like (purinergic) receptors	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-418217	G beta:gamma signalling through PLC beta	 15	1	1	0	15	2451	8868	0
R-HSA-418346	Platelet homeostasis	 63	0.503575825687765	1	14	49	2437	8834	1.02760777913777
R-HSA-418359	Reduction of cytosolic Ca++ levels	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-418360	Platelet calcium homeostasis	 19	0.613591939120194	1	4	15	2447	8868	0.973523159183148
R-HSA-418457	cGMP effects	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-418555	G alpha (s) signalling events	 76	0.791573043828974	1	14	62	2437	8821	0.851832764285254
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 20	0.95028969473943	1	2	18	2449	8865	0.462423500611995
R-HSA-418597	G alpha (z) signalling events	 39	0.945305875868289	1	5	34	2446	8849	0.59285064181025
R-HSA-418885	DCC mediated attractive signaling	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-418886	Netrin mediated repulsion signals	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-418889	Ligand-independent caspase activation via DCC	  8	1	1	0	8	2451	8875	0
R-HSA-418890	Role of second messengers in netrin-1 signaling	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-418990	Adherens junctions interactions	 23	0.996340855870662	1	1	22	2450	8861	0.201053695918259
R-HSA-419037	NCAM1 interactions	 25	0.286342449053089	1	7	18	2444	8865	1.29478580171359
R-HSA-419408	Lysosphingolipid and LPA receptors	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-419812	Calcitonin-like ligand receptors	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-420029	Tight junction interactions	 10	1	1	0	10	2451	8873	0
R-HSA-420092	Glucagon-type ligand receptors	 20	0.992387669376172	1	1	19	2450	8864	0.231211750305998
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-420597	Nectin/Necl  trans heterodimerization	  6	1	1	0	6	2451	8877	0
R-HSA-421270	Cell-cell junction organization	 34	0.99740721142097	1	2	32	2449	8851	0.272013823889409
R-HSA-421837	Clathrin derived vesicle budding	 53	0.0916969024137072	1	16	37	2435	8846	1.39599547354565
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-422356	Regulation of insulin secretion	 65	0.981805609242877	1	8	57	2443	8826	0.56913661613784
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	 57	0.946597146824694	1	8	49	2443	8834	0.649015439455432
R-HSA-425381	Bicarbonate transporters	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 65	0.860093492601996	1	11	54	2440	8829	0.78256284718953
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 23	0.765337144694179	1	4	19	2447	8864	0.804214783673035
R-HSA-425410	Metal ion SLC transporters	 20	0.839761735385776	1	3	17	2448	8866	0.693635250917993
R-HSA-425561	Sodium/Calcium exchangers	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.00666700266087695	0.616381472305583	5	2	2446	8881	3.30302500437139
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 26	0.941856532277737	1	3	23	2448	8860	0.533565577629225
R-HSA-427413	NoRC negatively regulates rRNA expression	 45	0.254165343359322	1	12	33	2439	8850	1.23312933496532
R-HSA-428157	Sphingolipid metabolism	 60	0.669888545567416	1	12	48	2439	8835	0.92484700122399
R-HSA-428540	Activation of Rac	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-428543	Inactivation of Cdc42 and Rac	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-428643	Organic anion transporters	  6	1	1	0	6	2451	8877	0
R-HSA-428890	Role of Abl in Robo-Slit signaling	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-428930	Thromboxane signalling through TP receptor	 18	0.780911847318683	1	3	15	2448	8868	0.770705834353325
R-HSA-429914	Deadenylation-dependent mRNA decay	 42	0.572959839523176	1	9	33	2442	8850	0.990907501311418
R-HSA-429947	Deadenylation of mRNA	 18	0.175701284424564	1	6	12	2445	8871	1.54141166870665
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-430116	GP1b-IX-V activation signalling	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 33	0.870901306862431	1	5	28	2446	8855	0.700641667593932
R-HSA-432142	Platelet sensitization by LDL	 15	0.413201927014538	1	4	11	2447	8872	1.23312933496532
R-HSA-432720	Lysosome Vesicle Biogenesis	 23	0.765337144694179	1	4	19	2447	8864	0.804214783673035
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 43	0.0641775185454765	1	14	29	2437	8854	1.50556488571347
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-435354	Zinc transporters	 14	0.611064798870095	1	3	11	2448	8872	0.990907501311418
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-437239	Recycling pathway of L1	 35	0.902070942175291	1	5	30	2446	8853	0.660605000874279
R-HSA-438064	Post NMDA receptor activation events	 32	0.937904265542276	1	4	28	2447	8855	0.578029375764994
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 16	0.979790609188797	1	1	15	2450	8868	0.289014687882497
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  7	1	1	0	7	2451	8876	0
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  5	1	1	0	5	2451	8878	0
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 15	0.974204996099233	1	1	14	2450	8869	0.30828233374133
R-HSA-442742	CREB phosphorylation through the activation of Ras	 27	0.866084112677026	1	4	23	2447	8860	0.685071852758511
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	 36	0.915039824793108	1	5	31	2446	8852	0.642254861961104
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 17	0.984167108294492	1	1	16	2450	8867	0.272013823889409
R-HSA-444257	RSK activation	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-445095	Interaction between L1 and Ankyrins	 24	0.978104012797265	1	2	22	2449	8861	0.385352917176663
R-HSA-445144	Signal transduction by L1	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-445355	Smooth Muscle Contraction	 29	0.992372900186369	1	2	27	2449	8856	0.318912759042755
R-HSA-445717	Aquaporin-mediated transport	 35	0.902070942175291	1	5	30	2446	8853	0.660605000874279
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 20	0.441643561521251	1	5	15	2446	8868	1.15605875152999
R-HSA-446107	Type I hemidesmosome assembly	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 55	0.93131932319706	1	8	47	2443	8836	0.672616000890175
R-HSA-446199	Synthesis of Dolichyl-phosphate	  5	1	1	0	5	2451	8878	0
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 46	0.981775896293154	1	5	41	2446	8842	0.502634239795647
R-HSA-446353	Cell-extracellular matrix interactions	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-446652	Interleukin-1 family signaling	 65	0.981805609242877	1	8	57	2443	8826	0.56913661613784
R-HSA-446728	Cell junction organization	 52	0.952330811966135	1	7	45	2444	8838	0.622493173900763
R-HSA-447038	NrCAM interactions	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-447041	CHL1 interactions	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-447043	Neurofascin interactions	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-447115	Interleukin-12 family signaling	 38	0.441045226203719	1	9	29	2442	8854	1.09521355408104
R-HSA-449836	Other interleukin signaling	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 28	0.755350632400901	1	5	23	2446	8860	0.825756251092848
R-HSA-450294	MAP kinase activation in TLR cascade	 47	0.714868207686185	1	9	38	2442	8845	0.885491809682544
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-450341	Activation of the AP-1 family of transcription factors	  8	1	1	0	8	2451	8875	0
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 38	0.97710355372979	1	4	34	2447	8849	0.486761579591574
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 16	0.705262354797824	1	3	13	2448	8870	0.867044063647491
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 64	0.979066101319399	1	8	56	2443	8827	0.578029375764994
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-451306	Ionotropic activity of kainate receptors	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-451326	Activation of kainate receptors upon glutamate binding	 23	0.996340855870662	1	1	22	2450	8861	0.201053695918259
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-453276	Regulation of mitotic cell cycle	 56	0.996685641673254	1	5	51	2446	8832	0.412878125546424
R-HSA-4551638	SUMOylation of chromatin organization proteins	 42	0.180099418245335	1	12	30	2439	8853	1.32121000174856
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 22	0.884407372956687	1	3	19	2448	8864	0.630577500834539
R-HSA-4570464	SUMOylation of RNA binding proteins	 31	0.518731843993708	1	7	24	2444	8859	1.04418209815612
R-HSA-4608870	Asymmetric localization of PCP proteins	 47	0.995420531075367	1	4	43	2447	8840	0.393551915414464
R-HSA-4615885	SUMOylation of DNA replication proteins	 29	0.621138441801237	1	6	23	2445	8860	0.956738277128266
R-HSA-4641257	Degradation of AXIN	 41	0.996615591630617	1	3	38	2448	8845	0.338358658984387
R-HSA-4641258	Degradation of DVL	 44	0.992070165443928	1	4	40	2447	8843	0.420385000556359
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 27	0.213221432967092	1	8	19	2443	8864	1.37014370551702
R-HSA-4641263	Regulation of FZD by ubiquitination	 12	0.498562181246513	1	3	9	2448	8874	1.15605875152999
R-HSA-4641265	Repression of WNT target genes	 13	1	1	0	13	2451	8870	0
R-HSA-4791275	Signaling by WNT in cancer	 26	0.504879837071549	1	6	20	2445	8863	1.06713115525845
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	 24	0.420811735291587	1	6	18	2445	8865	1.15605875152999
R-HSA-500657	Presynaptic function of Kainate receptors	 15	1	1	0	15	2451	8868	0
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 17	0.909766623497674	1	2	15	2449	8868	0.544027647778818
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 11	1	1	0	11	2451	8872	0
R-HSA-5173105	O-linked glycosylation	 58	0.906316201873146	1	9	49	2442	8834	0.717553707846199
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 19	0.939236898804065	1	2	17	2449	8866	0.486761579591574
R-HSA-5205647	Mitophagy	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-5210891	Uptake and function of anthrax toxins	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-5213460	RIPK1-mediated regulated necrosis	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-5218859	Regulated Necrosis	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-5218900	CASP8 activity is inhibited	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5218920	VEGFR2 mediated vascular permeability	 21	0.488129958903323	1	5	16	2446	8867	1.10100833479046
R-HSA-5223345	Miscellaneous transport and binding events	 20	0.656579033519929	1	4	16	2447	8867	0.92484700122399
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 47	0.580466799161184	1	10	37	2441	8846	0.98387978853616
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 34	0.305596047503792	1	9	25	2442	8858	1.22406220750234
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 45	0.254165343359322	1	12	33	2439	8850	1.23312933496532
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	1	1	0	5	2451	8878	0
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	1	1	0	5	2451	8878	0
R-HSA-525793	Myogenesis	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-5260271	Diseases of Immune System	 17	0.909766623497674	1	2	15	2449	8868	0.544027647778818
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 24	0.127599590143546	1	8	16	2443	8867	1.54141166870665
R-HSA-5334118	DNA methylation	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-5339562	Uptake and actions of bacterial toxins	 25	0.655630976027731	1	5	20	2446	8863	0.92484700122399
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 19	0.939236898804065	1	2	17	2449	8866	0.486761579591574
R-HSA-5357786	TNFR1-induced proapoptotic signaling	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-5357905	Regulation of TNFR1 signaling	 22	0.335100831398267	1	6	16	2445	8867	1.26115500166908
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 20	0.251856606183131	1	6	14	2445	8869	1.38727050183599
R-HSA-5358346	Hedgehog ligand biogenesis	 47	0.958617098222068	1	6	41	2445	8842	0.590327873121696
R-HSA-5358493	Synthesis of diphthamide-EEF2	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5358508	Mismatch Repair	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 14	0.167065286143015	1	5	9	2446	8874	1.6515125021857
R-HSA-5362517	Signaling by Retinoic Acid	 29	0.992372900186369	1	2	27	2449	8856	0.318912759042755
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 42	0.965464248014464	1	5	37	2446	8846	0.550504167395232
R-HSA-5365859	RA biosynthesis pathway	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-5368286	Mitochondrial translation initiation	 61	0.933907777119752	1	9	52	2442	8831	0.682264181230812
R-HSA-5368287	Mitochondrial translation	 66	0.964372515128273	1	9	57	2442	8826	0.630577500834539
R-HSA-5387390	Hh mutants abrogate ligand secretion	 43	0.970486576498964	1	5	38	2446	8845	0.537701744897669
R-HSA-5389840	Mitochondrial translation elongation	 60	0.984760631436418	1	7	53	2444	8830	0.539494084047328
R-HSA-539107	Activation of E2F1 target genes at G1/S	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-5419276	Mitochondrial translation termination	 61	0.986879933244217	1	7	54	2444	8829	0.530649918735076
R-HSA-5423646	Aflatoxin activation and detoxification	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-549127	Organic cation transport	  6	1	1	0	6	2451	8877	0
R-HSA-549132	Organic cation/anion/zwitterion transport	  9	1	1	0	9	2451	8874	0
R-HSA-5576886	Phase 4 - resting membrane potential	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-5576891	Cardiac conduction	 91	0.971695390444311	1	13	78	2438	8805	0.660605000874279
R-HSA-5576892	Phase 0 - rapid depolarisation	 30	0.971795393747427	1	3	27	2448	8856	0.462423500611995
R-HSA-5576893	Phase 2 - plateau phase	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-5578749	Transcriptional regulation by small RNAs	 48	0.73917351041847	1	9	39	2442	8844	0.867044063647491
R-HSA-5578768	Physiological factors	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5578775	Ion homeostasis	 43	0.927294551532267	1	6	37	2445	8846	0.645242093877203
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 17	0.909766623497674	1	2	15	2449	8868	0.544027647778818
R-HSA-5602498	MyD88 deficiency (TLR2/4)	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 48	0.996195732582368	1	4	44	2447	8839	0.385352917176663
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 75	0.951748856854928	1	11	64	2440	8819	0.678221134230926
R-HSA-5610780	Degradation of GLI1 by the proteasome	 45	0.993388008401433	1	4	41	2447	8842	0.411043111655107
R-HSA-5610783	Degradation of GLI2 by the proteasome	 45	0.993388008401433	1	4	41	2447	8842	0.411043111655107
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 45	0.993388008401433	1	4	41	2447	8842	0.411043111655107
R-HSA-5610787	Hedgehog 'off' state	 90	0.846246011114043	1	16	74	2435	8809	0.822086223310214
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 49	0.86090239617408	1	8	41	2443	8842	0.754977143856319
R-HSA-5619084	ABC transporter disorders	 46	0.896328581690136	1	7	39	2444	8844	0.703687935713906
R-HSA-5619115	Disorders of transmembrane transporters	 48	0.919303703108985	1	7	41	2444	8842	0.67436760505916
R-HSA-5619507	Activation of HOX genes during differentiation	 49	0.86090239617408	1	8	41	2443	8842	0.754977143856319
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 72	0.00151702931855087	0.616381472305583	27	45	2424	8838	1.73408812729498
R-HSA-5620916	VxPx cargo-targeting to cilium	 16	0.252730051086096	1	5	11	2446	8872	1.44507343941248
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 39	0.474931430952314	1	9	30	2442	8853	1.06713115525845
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 19	0.812284330105899	1	3	16	2448	8867	0.730142369387361
R-HSA-5620924	Intraflagellar transport	 42	0.0111054399790964	0.616381472305583	16	26	2435	8857	1.76161333566474
R-HSA-5621480	Dectin-2 family	  6	1	1	0	6	2451	8877	0
R-HSA-5621481	C-type lectin receptors (CLRs)	 94	0.98005838883355	1	13	81	2438	8802	0.639521862548504
R-HSA-5621575	CD209 (DC-SIGN) signaling	 18	0.925873470520048	1	2	16	2449	8867	0.513803889568883
R-HSA-5625740	RHO GTPases activate PKNs	 38	0.74419669129211	1	7	31	2444	8852	0.851832764285254
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 17	0.745327121691444	1	3	14	2448	8869	0.816041471668227
R-HSA-5625900	RHO GTPases activate CIT	 15	0.974204996099233	1	1	14	2450	8869	0.30828233374133
R-HSA-5625970	RHO GTPases activate KTN1	  8	0.239840346418036	1	3	5	2448	8878	1.73408812729498
R-HSA-5626467	RHO GTPases activate IQGAPs	 21	0.863686339633354	1	3	18	2448	8865	0.660605000874279
R-HSA-5627117	RHO GTPases Activate ROCKs	 15	0.974204996099233	1	1	14	2450	8869	0.30828233374133
R-HSA-5627123	RHO GTPases activate PAKs	 19	0.812284330105899	1	3	16	2448	8867	0.730142369387361
R-HSA-5628897	TP53 Regulates Metabolic Genes	 65	0.435734770331107	1	15	50	2436	8833	1.06713115525845
R-HSA-5632681	Ligand-receptor interactions	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5632684	Hedgehog 'on' state	 64	0.954144943296251	1	9	55	2442	8828	0.650283047735618
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 33	0.748697898249078	1	6	27	2445	8856	0.840770001112718
R-HSA-5635838	Activation of SMO	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	  5	0.0711201473144551	1	3	2	2448	8881	2.77454100367197
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	  5	0.0711201473144551	1	3	2	2448	8881	2.77454100367197
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-5654687	Downstream signaling of activated FGFR1	 17	0.0549816989972063	1	7	10	2444	8873	1.90409676722586
R-HSA-5654688	SHC-mediated cascade:FGFR1	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-5654689	PI-3K cascade:FGFR1	  9	0.00464319703835871	0.616381472305583	6	3	2445	8880	3.0828233374133
R-HSA-5654693	FRS-mediated FGFR1 signaling	 11	0.0170950200662536	0.719093747303053	6	5	2445	8878	2.52231000333816
R-HSA-5654695	PI-3K cascade:FGFR2	  9	0.00464319703835871	0.616381472305583	6	3	2445	8880	3.0828233374133
R-HSA-5654696	Downstream signaling of activated FGFR2	 15	0.0271923790796395	0.844258626663093	7	8	2444	8875	2.15797633618931
R-HSA-5654699	SHC-mediated cascade:FGFR2	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-5654700	FRS-mediated FGFR2 signaling	 11	0.0170950200662536	0.719093747303053	6	5	2445	8878	2.52231000333816
R-HSA-5654704	SHC-mediated cascade:FGFR3	 10	0.371645107075241	1	3	7	2448	8876	1.38727050183599
R-HSA-5654706	FRS-mediated FGFR3 signaling	 11	0.0676894659624027	1	5	6	2446	8877	2.1019250027818
R-HSA-5654708	Downstream signaling of activated FGFR3	 15	0.0842557473291921	1	6	9	2445	8874	1.84969400244798
R-HSA-5654710	PI-3K cascade:FGFR3	  9	0.0270918501059032	0.844258626663093	5	4	2446	8879	2.56901944784442
R-HSA-5654712	FRS-mediated FGFR4 signaling	 10	0.0446919905550624	1	5	5	2446	8878	2.31211750305998
R-HSA-5654716	Downstream signaling of activated FGFR4	 14	0.061430400029371	1	6	8	2445	8875	1.98181500262284
R-HSA-5654719	SHC-mediated cascade:FGFR4	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-5654720	PI-3K cascade:FGFR4	  8	0.0146203761794896	0.706110019927941	5	3	2446	8880	2.89014687882497
R-HSA-5654726	Negative regulation of FGFR1 signaling	 16	0.0113444442755629	0.616381472305583	8	8	2443	8875	2.31211750305998
R-HSA-5654727	Negative regulation of FGFR2 signaling	 15	0.0271923790796395	0.844258626663093	7	8	2444	8875	2.15797633618931
R-HSA-5654732	Negative regulation of FGFR3 signaling	 15	0.0842557473291921	1	6	9	2445	8874	1.84969400244798
R-HSA-5654733	Negative regulation of FGFR4 signaling	 14	0.061430400029371	1	6	8	2445	8875	1.98181500262284
R-HSA-5654736	Signaling by FGFR1	 28	0.0258458218639237	0.844258626663093	11	17	2440	8866	1.81666375240427
R-HSA-5654738	Signaling by FGFR2	 42	0.0255124590374354	0.844258626663093	15	27	2436	8856	1.6515125021857
R-HSA-5654741	Signaling by FGFR3	 23	0.103847887966445	1	8	15	2443	8868	1.60842956734607
R-HSA-5654743	Signaling by FGFR4	 22	0.0827731490262246	1	8	14	2443	8869	1.68154000222544
R-HSA-5655253	Signaling by FGFR2 in disease	 23	0.103847887966445	1	8	15	2443	8868	1.60842956734607
R-HSA-5655291	Signaling by FGFR4 in disease	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-5655302	Signaling by FGFR1 in disease	 27	0.0193923221196056	0.778481051344359	11	16	2440	8867	1.88394759508591
R-HSA-5655332	Signaling by FGFR3 in disease	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-5655862	Translesion synthesis by POLK	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-5656121	Translesion synthesis by POLI	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-5656169	Termination of translesion DNA synthesis	 18	0.346408264380791	1	5	13	2446	8870	1.28450972392221
R-HSA-5658442	Regulation of RAS by GAPs	 53	0.912362602180779	1	8	45	2443	8838	0.697997736772823
R-HSA-5660526	Response to metal ions	  9	1	1	0	9	2451	8874	0
R-HSA-5661231	Metallothioneins bind metals	  7	1	1	0	7	2451	8876	0
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 29	0.783311505442497	1	5	24	2446	8859	0.797281897606888
R-HSA-5663220	RHO GTPases Activate Formins	 81	0.953710408983512	1	12	69	2439	8814	0.685071852758511
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 62	0.996079845551938	1	6	56	2445	8827	0.447506613495479
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	  8	1	1	0	8	2451	8875	0
R-HSA-5668914	Diseases of metabolism	 21	0.29288708989862	1	6	15	2445	8868	1.32121000174856
R-HSA-5669034	TNFs bind their physiological receptors	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-5673000	RAF activation	 22	0.180317112566229	1	7	15	2444	8868	1.47134750194726
R-HSA-5674135	MAP2K and MAPK activation	 26	0.941856532277737	1	3	23	2448	8860	0.533565577629225
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-5675221	Negative regulation of MAPK pathway	 33	0.42347454081045	1	8	25	2443	8858	1.12102666815029
R-HSA-5675482	Regulation of necroptotic cell death	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 46	0.994493923840317	1	4	42	2447	8841	0.402107391836518
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-5676934	Protein repair	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 44	0.936651357224282	1	6	38	2445	8845	0.630577500834539
R-HSA-5682910	LGI-ADAM interactions	 13	0.957978791291737	1	1	12	2450	8871	0.35571038508615
R-HSA-5683826	Surfactant metabolism	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 23	0.576254052069736	1	5	18	2446	8865	1.00526847959129
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-5686938	Regulation of TLR by endogenous ligand	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-5687128	MAPK6/MAPK4 signaling	 66	0.873185082123021	1	11	55	2440	8828	0.770705834353325
R-HSA-5689603	UCH proteinases	 66	0.964372515128273	1	9	57	2442	8826	0.630577500834539
R-HSA-5689896	Ovarian tumor domain proteases	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-5689901	Metalloprotease DUBs	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-5690714	CD22 mediated BCR regulation	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-5693532	DNA Double-Strand Break Repair	 79	0.837134777778716	1	14	65	2437	8818	0.819484684628852
R-HSA-5693537	Resolution of D-Loop Structures	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-5693538	Homology Directed Repair	 60	0.864448707201549	1	10	50	2441	8833	0.770705834353325
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 33	0.947146052946393	1	4	29	2447	8854	0.560513334075146
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 58	0.834528308959847	1	10	48	2441	8835	0.797281897606888
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 31	0.927214437210831	1	4	27	2447	8856	0.596675484660639
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 23	0.576254052069736	1	5	18	2446	8865	1.00526847959129
R-HSA-5693606	DNA Double Strand Break Response	 33	0.947146052946393	1	4	29	2447	8854	0.560513334075146
R-HSA-5693607	Processing of DNA double-strand break ends	 42	0.965464248014464	1	5	37	2446	8846	0.550504167395232
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 22	0.533138525816575	1	5	17	2446	8866	1.0509625013909
R-HSA-5694530	Cargo concentration in the ER	 23	0.377922631305196	1	6	17	2445	8866	1.20632217550955
R-HSA-5696394	DNA Damage Recognition in GG-NER	 24	0.978104012797265	1	2	22	2449	8861	0.385352917176663
R-HSA-5696395	Formation of Incision Complex in GG-NER	 29	0.156552141070189	1	9	20	2442	8863	1.4351074156924
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 13	0.556966647960213	1	3	10	2448	8873	1.06713115525845
R-HSA-5696398	Nucleotide Excision Repair	 71	0.472342345768423	1	16	55	2435	8828	1.04208112813971
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 55	0.539181111324505	1	12	43	2439	8840	1.00892400133526
R-HSA-5696400	Dual Incision in GG-NER	 26	0.0894826546679778	1	9	17	2442	8866	1.60069673288768
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 23	0.765337144694179	1	4	19	2447	8864	0.804214783673035
R-HSA-611105	Respiratory electron transport	 60	0.669888545567416	1	12	48	2439	8835	0.92484700122399
R-HSA-622312	Inflammasomes	 12	0.946368602751105	1	1	11	2450	8872	0.385352917176663
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 52	0.0426335351761416	1	17	35	2434	8848	1.51176913661614
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 34	0.182778965505879	1	10	24	2441	8859	1.36006911944704
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 49	0.24822199386739	1	13	36	2438	8847	1.22683785876652
R-HSA-6782135	Dual incision in TC-NER	 42	0.102738047904735	1	13	29	2438	8854	1.4313108352276
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 39	0.118293051168422	1	12	27	2439	8856	1.4228415403446
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 29	0.0773550885309152	1	10	19	2441	8864	1.59456379521378
R-HSA-6783310	Fanconi Anemia Pathway	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-6783589	Interleukin-6 family signaling	 19	0.0957534149087145	1	7	12	2444	8871	1.70366552857051
R-HSA-6783783	Interleukin-10 signaling	 24	0.997133762091244	1	1	23	2450	8860	0.192676458588331
R-HSA-6784531	tRNA processing in the nucleus	 45	0.519683084860268	1	10	35	2441	8848	1.02760777913777
R-HSA-6785631	ERBB2 Regulates Cell Motility	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-6785807	Interleukin-4 and 13 signaling	 68	0.97249906229672	1	9	59	2442	8824	0.61203110375117
R-HSA-6787450	tRNA modification in the mitochondrion	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 27	0.866084112677026	1	4	23	2447	8860	0.685071852758511
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 32	0.555612104948579	1	7	25	2444	8858	1.01155140758874
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	 80	0.576635198467386	1	17	63	2434	8820	0.98264993880049
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 31	0.518731843993708	1	7	24	2444	8859	1.04418209815612
R-HSA-6794361	Neurexins and neuroligins	 48	0.919303703108985	1	7	41	2444	8842	0.67436760505916
R-HSA-6794362	Protein-protein interactions at synapses	 74	0.972839198624185	1	10	64	2441	8819	0.624896622448642
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 34	0.0472661374637211	1	12	22	2439	8861	1.63208294333645
R-HSA-6798163	Choline catabolism	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-6799198	Complex I biogenesis	 34	0.887410544422599	1	5	29	2446	8854	0.680034559723522
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 27	0.866084112677026	1	4	23	2447	8860	0.685071852758511
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 24	0.978104012797265	1	2	22	2449	8861	0.385352917176663
R-HSA-6802949	Signaling by RAS mutants	 36	0.688369597714573	1	7	29	2444	8854	0.899156806745546
R-HSA-6802952	Signaling by BRAF and RAF fusions	 45	0.78736711176867	1	8	37	2443	8846	0.822086223310214
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 27	0.866084112677026	1	4	23	2447	8860	0.685071852758511
R-HSA-6802957	Oncogenic MAPK signaling	 56	0.566868235887854	1	12	44	2439	8839	0.990907501311418
R-HSA-6803157	Antimicrobial peptides	 23	1	1	0	23	2451	8860	0
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	  8	0.0723449015945121	1	4	4	2447	8879	2.31211750305998
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-6803529	FGFR2 alternative splicing	 19	0.0957534149087145	1	7	12	2444	8871	1.70366552857051
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 14	0.358606761290642	1	4	10	2447	8873	1.32121000174856
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 55	0.780451433676718	1	10	45	2441	8838	0.840770001112718
R-HSA-6804757	Regulation of TP53 Degradation	 25	0.0717358386304538	1	9	16	2442	8867	1.66472460220318
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 25	0.930697895524245	1	3	22	2448	8861	0.554908200734394
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 11	0.436465478131371	1	3	8	2448	8875	1.26115500166908
R-HSA-6805567	Keratinization	 22	1	1	0	22	2451	8861	0
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 25	0.0717358386304538	1	9	16	2442	8867	1.66472460220318
R-HSA-6806667	Metabolism of fat-soluble vitamins	 25	0.930697895524245	1	3	22	2448	8861	0.554908200734394
R-HSA-6806834	Signaling by MET	 55	0.409651931179328	1	13	42	2438	8841	1.09300100144653
R-HSA-6807004	Negative regulation of MET activity	 14	0.061430400029371	1	6	8	2445	8875	1.98181500262284
R-HSA-6807070	PTEN Regulation	100	0.897227594475448	1	17	83	2434	8800	0.786119951040392
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 51	0.197064583434443	1	14	37	2437	8846	1.26939784481724
R-HSA-6807878	COPI-mediated anterograde transport	 72	0.809441772826427	1	13	59	2438	8824	0.834931320549436
R-HSA-6809371	Formation of the cornified envelope	 21	1	1	0	21	2451	8862	0
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 61	0.933907777119752	1	9	52	2442	8831	0.682264181230812
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 37	0.717215809044273	1	7	30	2444	8853	0.874855271428099
R-HSA-6811438	Intra-Golgi traffic	 32	0.00414198191532922	0.616381472305583	14	18	2437	8865	2.02310281517748
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 34	0.0204147930462977	0.782967356834475	13	21	2438	8862	1.76808985528116
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  7	1	1	0	7	2451	8876	0
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 55	0.291455835836078	1	14	41	2437	8842	1.17707800155781
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 30	0.971795393747427	1	3	27	2448	8856	0.462423500611995
R-HSA-6814848	Glycerophospholipid catabolism	  5	1	1	0	5	2451	8878	0
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	1	1	0	5	2451	8878	0
R-HSA-68689	CDC6 association with the ORC:origin complex	  6	1	1	0	6	2451	8877	0
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 43	0.997733567168891	1	3	40	2448	8843	0.322621046938601
R-HSA-68867	Assembly of the pre-replicative complex	 48	0.999181356164234	1	3	45	2448	8838	0.289014687882497
R-HSA-68874	M/G1 Transition	 57	0.999875066792592	1	3	54	2448	8829	0.243380789795787
R-HSA-68875	Mitotic Prophase	 74	0.327962635322409	1	18	56	2433	8827	1.12481392040756
R-HSA-68884	Mitotic Telophase/Cytokinesis	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-68949	Orc1 removal from chromatin	 52	0.998208203546236	1	4	48	2447	8835	0.35571038508615
R-HSA-68962	Activation of the pre-replicative complex	 20	1	1	0	20	2451	8863	0
R-HSA-69002	DNA Replication Pre-Initiation	 57	0.999875066792592	1	3	54	2448	8829	0.243380789795787
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 37	0.99254845264291	1	3	34	2448	8849	0.374937973469185
R-HSA-69052	Switching of origins to a post-replicative state	 52	0.998208203546236	1	4	48	2447	8835	0.35571038508615
R-HSA-69091	Polymerase switching	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-69109	Leading Strand Synthesis	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-69166	Removal of the Flap Intermediate	  9	1	1	0	9	2451	8874	0
R-HSA-69183	Processive synthesis on the lagging strand	  9	1	1	0	9	2451	8874	0
R-HSA-69186	Lagging Strand Synthesis	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-69190	DNA strand elongation	 20	0.95028969473943	1	2	18	2449	8865	0.462423500611995
R-HSA-69202	Cyclin E associated events during G1/S transition 	 58	0.979532251775689	1	7	51	2444	8832	0.558097328324822
R-HSA-69205	G1/S-Specific Transcription	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-69206	G1/S Transition	 89	0.996496517318056	1	10	79	2441	8804	0.51957696697977
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 37	0.99254845264291	1	3	34	2448	8849	0.374937973469185
R-HSA-69231	Cyclin D associated events in G1	 28	0.131973745454552	1	9	19	2442	8864	1.48636125196713
R-HSA-69236	G1 Phase	 28	0.131973745454552	1	9	19	2442	8864	1.48636125196713
R-HSA-69239	Synthesis of DNA	 69	0.998819168873009	1	6	63	2445	8820	0.402107391836518
R-HSA-69242	S Phase	 94	0.990394931457164	1	12	82	2439	8801	0.590327873121696
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	 15	0.413201927014538	1	4	11	2447	8872	1.23312933496532
R-HSA-69298	Association of licensing factors with the pre-replicative complex	  6	1	1	0	6	2451	8877	0
R-HSA-69300	Removal of licensing factors from origins	 53	0.998519445982267	1	4	49	2447	8834	0.348998868386411
R-HSA-69304	Regulation of DNA replication	 53	0.998519445982267	1	4	49	2447	8834	0.348998868386411
R-HSA-69306	DNA Replication	 72	0.999304605681637	1	6	66	2445	8817	0.385352917176663
R-HSA-69416	Dimerization of procaspase-8	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-69473	G2/M DNA damage checkpoint	 45	0.993388008401433	1	4	41	2447	8842	0.411043111655107
R-HSA-69481	G2/M Checkpoints	 93	0.999939942020069	1	7	86	2444	8797	0.348060699385373
R-HSA-69541	Stabilization of p53	 41	0.959663775744552	1	5	36	2446	8847	0.563931098307311
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 48	0.964233297523937	1	6	42	2445	8841	0.578029375764994
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 48	0.964233297523937	1	6	42	2445	8841	0.578029375764994
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 37	0.972830854832817	1	4	33	2447	8850	0.499917297958914
R-HSA-69610	p53-Independent DNA Damage Response	 37	0.972830854832817	1	4	33	2447	8850	0.499917297958914
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 37	0.972830854832817	1	4	33	2447	8850	0.499917297958914
R-HSA-69615	G1/S DNA Damage Checkpoints	 48	0.964233297523937	1	6	42	2445	8841	0.578029375764994
R-HSA-69618	Mitotic Spindle Checkpoint	 62	0.94138521535499	1	9	53	2442	8830	0.671259920243219
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 56	0.972683127025034	1	7	49	2444	8834	0.578029375764994
R-HSA-70171	Glycolysis	 50	0.87565840797503	1	8	42	2443	8841	0.739877600979192
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-70263	Gluconeogenesis	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-70268	Pyruvate metabolism	 23	0.902267907196063	1	3	20	2448	8863	0.603161087754776
R-HSA-70326	Glucose metabolism	 65	0.920531477981936	1	10	55	2441	8828	0.7114207701723
R-HSA-70370	Galactose catabolism	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 27	0.363576196093816	1	7	20	2444	8863	1.19887574232739
R-HSA-70635	Urea cycle	  5	1	1	0	5	2451	8878	0
R-HSA-70895	Branched-chain amino acid catabolism	 18	0.000327000148048375	0.426408193055082	11	7	2440	8876	2.82592139262886
R-HSA-71064	Lysine catabolism	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-71182	Phenylalanine and tyrosine catabolism	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-71240	Tryptophan catabolism	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-71288	Creatine metabolism	  6	1	1	0	6	2451	8877	0
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	 11	0.723570814747436	1	2	9	2449	8874	0.840770001112718
R-HSA-71384	Ethanol oxidation	  5	1	1	0	5	2451	8878	0
R-HSA-71403	Citric acid cycle (TCA cycle)	 16	1	1	0	16	2451	8867	0
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 40	0.983821531221465	1	4	36	2447	8847	0.462423500611995
R-HSA-72086	mRNA Capping	 17	0.141706992482981	1	6	11	2445	8872	1.63208294333645
R-HSA-72165	mRNA Splicing - Minor Pathway	 33	0.157885760005415	1	10	23	2441	8860	1.40128333518786
R-HSA-72187	mRNA 3'-end processing	 44	0.00107787233237962	0.616381472305583	19	25	2432	8858	1.99682875264271
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 60	0.011827226128306	0.616908114852441	21	39	2430	8844	1.61848225214198
R-HSA-72306	tRNA processing	 79	0.114757952693884	1	22	57	2429	8826	1.28776164727391
R-HSA-72312	rRNA processing	 90	0.588805802758133	1	19	71	2432	8812	0.976227390180879
R-HSA-72613	Eukaryotic Translation Initiation	 40	0.359838339073574	1	10	30	2441	8853	1.15605875152999
R-HSA-72649	Translation initiation complex formation	 21	0.696214109900307	1	4	17	2447	8866	0.880806667832372
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-72689	Formation of a pool of free 40S subunits	 26	0.32459533157948	1	7	19	2444	8864	1.24498634780153
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 18	0.567403493555252	1	4	14	2447	8869	1.02760777913777
R-HSA-72702	Ribosomal scanning and start codon recognition	 22	0.533138525816575	1	5	17	2446	8866	1.0509625013909
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 34	0.305596047503792	1	9	25	2442	8858	1.22406220750234
R-HSA-72731	Recycling of eIF2:GDP	  8	0.543438663923805	1	2	6	2449	8877	1.15605875152999
R-HSA-72737	Cap-dependent Translation Initiation	 40	0.359838339073574	1	10	30	2441	8853	1.15605875152999
R-HSA-72764	Eukaryotic Translation Termination	 21	0.149280396894409	1	7	14	2444	8869	1.54141166870665
R-HSA-727802	Transport of nucleotide sugars	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-73728	RNA Polymerase I Promoter Opening	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-73762	RNA Polymerase I Transcription Initiation	 33	0.42347454081045	1	8	25	2443	8858	1.12102666815029
R-HSA-73772	RNA Polymerase I Promoter Escape	 19	0.212600301124187	1	6	13	2445	8870	1.46028473877472
R-HSA-73776	RNA Polymerase II Promoter Escape	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-73777	RNA Polymerase I Chain Elongation	 32	0.38701662629774	1	8	24	2443	8859	1.15605875152999
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-73780	RNA Polymerase III Chain Elongation	 15	0.867275994136022	1	2	13	2449	8870	0.61656466748266
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-73854	RNA Polymerase I Promoter Clearance	 46	0.550469076652908	1	10	36	2441	8847	1.00526847959129
R-HSA-73856	RNA Polymerase II Transcription Termination	 49	0.00473320625964268	0.616381472305583	19	30	2432	8853	1.79307071665876
R-HSA-73863	RNA Polymerase I Transcription Termination	 20	0.251856606183131	1	6	14	2445	8869	1.38727050183599
R-HSA-73864	RNA Polymerase I Transcription	 48	0.609545229179617	1	10	38	2441	8845	0.963382292941657
R-HSA-73884	Base Excision Repair	 25	0.821513848199238	1	4	21	2447	8862	0.739877600979192
R-HSA-73886	Chromosome Maintenance	 45	0.882894616167028	1	7	38	2444	8845	0.719325445396437
R-HSA-73887	Death Receptor Signalling	 35	0.116425134922051	1	11	24	2440	8859	1.45333100192341
R-HSA-73893	DNA Damage Bypass	 30	0.183161990441096	1	9	21	2442	8862	1.38727050183599
R-HSA-73928	Depyrimidination	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-73929	Base-Excision Repair, AP Site Formation	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 25	0.821513848199238	1	4	21	2447	8862	0.739877600979192
R-HSA-73942	DNA Damage Reversal	  6	1	1	0	6	2451	8877	0
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  6	1	1	0	6	2451	8877	0
R-HSA-73980	RNA Polymerase III Transcription Termination	 20	0.839761735385776	1	3	17	2448	8866	0.693635250917993
R-HSA-74158	RNA Polymerase III Transcription	 34	0.775147729013459	1	6	28	2445	8855	0.816041471668227
R-HSA-74182	Ketone body metabolism	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-74217	Purine salvage	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-74259	Purine catabolism	 10	0.371645107075241	1	3	7	2448	8876	1.38727050183599
R-HSA-74749	Signal attenuation	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 34	0.775147729013459	1	6	28	2445	8855	0.816041471668227
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	  7	1	1	0	7	2451	8876	0
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 22	0.533138525816575	1	5	17	2446	8866	1.0509625013909
R-HSA-75105	Fatty acyl-CoA biosynthesis	 27	0.0020084336485529	0.616381472305583	13	14	2438	8869	2.22648352146516
R-HSA-75153	Apoptotic execution  phase	 37	0.0412627442532568	1	13	24	2438	8859	1.62473121836647
R-HSA-75158	TRAIL  signaling	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-75205	Dissolution of Fibrin Clot	  8	1	1	0	8	2451	8875	0
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 37	0.99254845264291	1	3	34	2448	8849	0.374937973469185
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 20	0.00470863512528803	0.616381472305583	10	10	2441	8873	2.31211750305998
R-HSA-75892	Platelet Adhesion to exposed collagen	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-75893	TNF signaling	 29	0.0773550885309152	1	10	19	2441	8864	1.59456379521378
R-HSA-75953	RNA Polymerase II Transcription Initiation	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-75955	RNA Polymerase II Transcription Elongation	 35	0.0106068322651534	0.616381472305583	14	21	2437	8862	1.84969400244798
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	 89	0.833357460183862	1	16	73	2435	8810	0.831323147167632
R-HSA-76009	Platelet Aggregation (Plug Formation)	 21	0.863686339633354	1	3	18	2448	8865	0.660605000874279
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 31	0.350679343077405	1	8	23	2443	8860	1.19335096932128
R-HSA-76046	RNA Polymerase III Transcription Initiation	 29	0.783311505442497	1	5	24	2446	8859	0.797281897606888
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 24	0.794972588651797	1	4	20	2447	8863	0.770705834353325
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 15	0.208470055549927	1	5	10	2446	8873	1.54141166870665
R-HSA-77111	Synthesis of Ketone Bodies	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 25	0.821513848199238	1	4	21	2447	8862	0.739877600979192
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-77387	Insulin receptor recycling	 16	0.979790609188797	1	1	15	2450	8868	0.289014687882497
R-HSA-774815	Nucleosome assembly	 23	0.765337144694179	1	4	19	2447	8864	0.804214783673035
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-77595	Processing of Intronless Pre-mRNAs	 17	0.298989658837395	1	5	12	2446	8871	1.36006911944704
R-HSA-804914	Transport of fatty acids	  5	1	1	0	5	2451	8878	0
R-HSA-844456	The NLRP3 inflammasome	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-877300	Interferon gamma signaling	 50	0.664520495019787	1	10	40	2441	8843	0.92484700122399
R-HSA-877312	Regulation of IFNG signaling	 10	0.00949170965674402	0.616381472305583	6	4	2445	8879	2.77454100367197
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-879518	Transport of organic anions	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-8848021	Signaling by PTK6	 40	0.659687050905071	1	8	32	2443	8851	0.92484700122399
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-8849473	PTK6 Expression	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8849932	Synaptic adhesion-like molecules	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8851680	Butyrophilin (BTN) family interactions	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-8851805	MET activates RAS signaling	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-8851907	MET activates PI3K/AKT signaling	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8852135	Protein ubiquitination	 47	0.439477503372287	1	11	36	2440	8847	1.08226776738978
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 50	0.99945832012013	1	3	47	2448	8836	0.277454100367197
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	  9	0.305486848234355	1	3	6	2448	8877	1.54141166870665
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 41	0.986433180462212	1	4	37	2447	8846	0.451144878645849
R-HSA-8854214	TBC/RABGAPs	 30	0.993842722074865	1	2	28	2449	8855	0.30828233374133
R-HSA-8854518	AURKA Activation by TPX2	 52	0.0098606938414922	0.616381472305583	19	33	2432	8850	1.68962432915921
R-HSA-8856688	Golgi-to-ER retrograde transport	 89	0.833357460183862	1	16	73	2435	8810	0.831323147167632
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 72	0.19779383057895	1	19	53	2432	8830	1.2202842377261
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 18	0.567403493555252	1	4	14	2447	8869	1.02760777913777
R-HSA-8863678	Neurodegenerative Diseases	 18	0.567403493555252	1	4	14	2447	8869	1.02760777913777
R-HSA-8863795	Downregulation of ERBB2 signaling	 21	0.863686339633354	1	3	18	2448	8865	0.660605000874279
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 26	0.845148347080803	1	4	22	2447	8861	0.7114207701723
R-HSA-8865999	MET activates PTPN11	  5	0.296289295190874	1	2	3	2449	8880	1.84969400244798
R-HSA-8866376	Reelin signalling pathway	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-8866427	VLDLR internalisation and degradation	 10	1	1	0	10	2451	8873	0
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 33	0.591187602985767	1	7	26	2444	8857	0.980898334631505
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-8868766	rRNA processing in the mitochondrion	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-8868773	rRNA processing in the nucleus and cytosol	 84	0.5605840042738	1	18	66	2433	8817	0.990907501311418
R-HSA-8873719	RAB geranylgeranylation	 46	0.981775896293154	1	5	41	2446	8842	0.502634239795647
R-HSA-8874081	MET activates PTK2 signaling	 21	0.863686339633354	1	3	18	2448	8865	0.660605000874279
R-HSA-8874211	CREB3 factors activate genes	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	  9	0.108547342785399	1	4	5	2447	8878	2.05521555827553
R-HSA-8875513	MET interacts with TNS proteins	  5	1	1	0	5	2451	8878	0
R-HSA-8875555	MET activates RAP1 and RAC1	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-8875656	MET receptor recycling	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-8875878	MET promotes cell motility	 30	0.808728421334544	1	5	25	2446	8858	0.770705834353325
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 70	0.675440523729036	1	14	56	2437	8827	0.92484700122399
R-HSA-8876384	Listeria monocytogenes entry into host cells	 12	0.250175368785946	1	4	8	2447	8875	1.54141166870665
R-HSA-8876725	Protein methylation	 11	0.198790784258893	1	4	7	2447	8876	1.68154000222544
R-HSA-8878159	Transcriptional regulation by RUNX3	 83	0.999641832023994	1	7	76	2444	8807	0.389995723407707
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	0.987596145810636	1	1	17	2450	8866	0.256901944784442
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	 16	0.0395185505939213	1	7	9	2444	8874	2.02310281517748
R-HSA-8934903	Receptor Mediated Mitophagy	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	  5	1	1	0	5	2451	8878	0
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	 41	0.157996169576593	1	12	29	2439	8854	1.35343463593755
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	 65	0.992892777682262	1	7	58	2444	8825	0.49799453912061
R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	 24	0.0214472300150938	0.799062512562353	10	14	2441	8869	1.92676458588331
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	  6	0.119795162156837	1	3	3	2448	8880	2.31211750305998
R-HSA-8941856	RUNX3 regulates NOTCH signaling	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-8941858	Regulation of RUNX3 expression and activity	 41	0.999444483385007	1	2	39	2449	8844	0.225572439322924
R-HSA-8943723	Regulation of PTEN mRNA translation	  9	0.0270918501059032	0.844258626663093	5	4	2446	8879	2.56901944784442
R-HSA-8943724	Regulation of PTEN gene transcription	 38	0.74419669129211	1	7	31	2444	8852	0.851832764285254
R-HSA-8948216	Collagen chain trimerization	 23	0.576254052069736	1	5	18	2446	8865	1.00526847959129
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	  8	0.0146203761794896	0.706110019927941	5	3	2446	8880	2.89014687882497
R-HSA-8948747	Regulation of PTEN localization	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8948751	Regulation of PTEN stability and activity	 53	0.998519445982267	1	4	49	2447	8834	0.348998868386411
R-HSA-8949215	Mitochondrial calcium ion transport	 14	0.967076395968352	1	1	13	2450	8870	0.330302500437139
R-HSA-8949613	Cristae formation	 18	0.780911847318683	1	3	15	2448	8868	0.770705834353325
R-HSA-8949664	Processing of SMDT1	 11	0.931552264309148	1	1	10	2450	8873	0.420385000556359
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	 24	0.794972588651797	1	4	20	2447	8863	0.770705834353325
R-HSA-8951430	RUNX3 regulates WNT signaling	  8	1	1	0	8	2451	8875	0
R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	 17	0.909766623497674	1	2	15	2449	8868	0.544027647778818
R-HSA-8951936	RUNX3 regulates p14-ARF	  8	1	1	0	8	2451	8875	0
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	 22	0.966905683824724	1	2	20	2449	8863	0.420385000556359
R-HSA-8956319	Nucleobase catabolism	 19	0.394196822686721	1	5	14	2446	8869	1.21690394897893
R-HSA-8956320	Nucleobase biosynthesis	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-8956321	Nucleotide salvage	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-8957275	Post-translational protein phosphorylation	 67	0.936655112563976	1	10	57	2441	8826	0.690184329271634
R-HSA-8957322	Metabolism of steroids	 90	0.0637703978397556	1	26	64	2425	8819	1.3358901128791
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	  9	0.611424896977933	1	2	7	2449	8876	1.02760777913777
R-HSA-8963896	HDL assembly	  5	0.70435093460773	1	1	4	2450	8879	0.92484700122399
R-HSA-8963898	Plasma lipoprotein assembly	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-8963899	Plasma lipoprotein remodeling	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-8964038	LDL clearance	 14	0.83970993049575	1	2	12	2449	8871	0.660605000874279
R-HSA-8964043	Plasma lipoprotein clearance	 20	0.95028969473943	1	2	18	2449	8865	0.462423500611995
R-HSA-8978934	Metabolism of cofactors	  6	1	1	0	6	2451	8877	0
R-HSA-8979227	Triglyceride metabolism	 19	0.812284330105899	1	3	16	2448	8867	0.730142369387361
R-HSA-8982491	Glycogen metabolism	 20	0.656579033519929	1	4	16	2447	8867	0.92484700122399
R-HSA-8984722	Interleukin-35 Signalling	  6	0.384536361707892	1	2	4	2449	8879	1.54141166870665
R-HSA-901032	ER Quality Control Compartment (ERQC)	 13	0.129338541102428	1	5	8	2446	8875	1.77855192543075
R-HSA-901042	Calnexin/calreticulin cycle	 18	0.175701284424564	1	6	12	2445	8871	1.54141166870665
R-HSA-909733	Interferon alpha/beta signaling	 46	0.808048236823997	1	8	38	2443	8845	0.804214783673035
R-HSA-912446	Meiotic recombination	 22	0.73245312858558	1	4	18	2447	8865	0.840770001112718
R-HSA-912631	Regulation of signaling by CBL	 12	0.768572541447621	1	2	10	2449	8873	0.770705834353325
R-HSA-912694	Regulation of IFNA signaling	  9	0.108547342785399	1	4	5	2447	8878	2.05521555827553
R-HSA-913709	O-linked glycosylation of mucins	 31	0.689225745659518	1	6	25	2445	8858	0.895013226990958
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 17	0.518293442627594	1	4	13	2447	8870	1.08805529555764
R-HSA-917937	Iron uptake and transport	 37	0.99254845264291	1	3	34	2448	8849	0.374937973469185
R-HSA-917977	Transferrin endocytosis and recycling	 21	0.863686339633354	1	3	18	2448	8865	0.660605000874279
R-HSA-918233	TRAF3-dependent IRF activation pathway	 10	0.671369844453606	1	2	8	2449	8875	0.92484700122399
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 39	0.0615273567086404	1	13	26	2438	8857	1.54141166870665
R-HSA-933541	TRAF6 mediated IRF7 activation	 15	0.660530516833985	1	3	12	2448	8871	0.92484700122399
R-HSA-933542	TRAF6 mediated NF-kB activation	 19	0.812284330105899	1	3	16	2448	8867	0.730142369387361
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	  8	0.857729307014032	1	1	7	2450	8876	0.578029375764994
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	 26	0.69152410435063	1	5	21	2446	8862	0.889275962715375
R-HSA-936837	Ion transport by P-type ATPases	 40	0.659687050905071	1	8	32	2443	8851	0.92484700122399
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 10	0.151117577605624	1	4	6	2447	8877	1.84969400244798
R-HSA-937039	IRAK1 recruits IKK complex	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-937041	IKK complex recruitment mediated by RIP1	 13	0.303880625534177	1	4	9	2447	8874	1.4228415403446
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling 	 74	0.433764055252215	1	17	57	2434	8826	1.06232425816269
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	  5	1	1	0	5	2451	8878	0
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 65	0.77654545640739	1	12	53	2439	8830	0.85370492420676
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	  6	0.768313849187698	1	1	5	2450	8878	0.770705834353325
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 67	0.811644851935794	1	12	55	2439	8828	0.828221195125961
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	  7	0.177029554609215	1	3	4	2448	8879	1.98181500262284
R-HSA-975298	Ligand-gated ion channel transport	 10	0.912644859803538	1	1	9	2450	8874	0.462423500611995
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 16	0.890420799755764	1	2	14	2449	8869	0.578029375764994
R-HSA-975577	N-Glycan antennae elongation	  9	1	1	0	9	2451	8874	0
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	  7	0.467539084547363	1	2	5	2449	8878	1.32121000174856
R-HSA-975634	Retinoid metabolism and transport	 24	0.917595809845244	1	3	21	2448	8862	0.578029375764994
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 62	0.814379761740266	1	11	51	2440	8832	0.820428791408378
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 22	0.180317112566229	1	7	15	2444	8868	1.47134750194726
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 39	0.0615273567086404	1	13	26	2438	8857	1.54141166870665
R-HSA-977068	Termination of O-glycan biosynthesis	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-977225	Amyloid fiber formation	 32	0.937904265542276	1	4	28	2447	8855	0.578029375764994
R-HSA-977347	Serine biosynthesis	  7	0.818442976627754	1	1	6	2450	8877	0.660605000874279
R-HSA-977441	GABA A receptor activation	  9	0.888517358268544	1	1	8	2450	8875	0.513803889568883
R-HSA-977443	GABA receptor activation	 40	0.99587053715488	1	3	37	2448	8846	0.346817625458996
R-HSA-977444	GABA B receptor activation	 31	0.995033811541758	1	2	29	2449	8854	0.298337742330319
R-HSA-977606	Regulation of Complement cascade	 24	0.917595809845244	1	3	21	2448	8862	0.578029375764994
R-HSA-982772	Growth hormone receptor signaling	 15	0.208470055549927	1	5	10	2446	8873	1.54141166870665
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 17	0.298989658837395	1	5	12	2446	8871	1.36006911944704
R-HSA-983189	Kinesins	 32	0.980572027487262	1	3	29	2448	8854	0.433522031823745
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	 90	0.588805802758133	1	19	71	2432	8812	0.976227390180879
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 32	0.38701662629774	1	8	24	2443	8859	1.15605875152999
R-HSA-991365	Activation of GABAB receptors	 31	0.995033811541758	1	2	29	2449	8854	0.298337742330319
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.807046340263514	1	2	11	2449	8872	0.7114207701723
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 18	1	1	0	18	2451	8865	0
